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Yue Fu 
CHARACTERIZATION OF THE COPPER RESISTANCE MECHANISM IN 
STREPTOCOCCUS PNEUMONIAE 
 
Pneumococcal related disease is an infection caused by Streptococcus 
pneumoniae (pneumococcus), including but not limited to otitis media, pneumoniae and 
meningitis. About 40 % of the infections are caused by drug resistant Streptococcus 
pneumoniae (DRSP). The prevalence of DRSP requires identifying novel targets for 
fighting against pneumococcal related diseases. The bacterial copper homeostasis 
machinery emerges as one important determinant for survival and virulence for bacteria 
in human host and serves as one potential drug development target. One cop operon 
(copY-cupA-copA) has been demonstrated to be essential for copper resistance in S 
.pneumoniae cells. The transcription of the cop operon is induced in S. pneumoniae 
isolated from  the lungs and nasopharynx of intranasally infected mice and is required for 
bacterial growth in nasopharynx. The cop operon encodes three proteins, the copper-
specific transcriptional regulator CopY, a protein of unknown function prior to this thesis 
work CupA and a copper-exporting P1B type ATPase CopA. In my thesis work, CupA has 
been shown to represent a novel class of copper chaperone widely distributed among 
lactobacillus and streptococcus, which lack CopZ-like Cu(I) chaperones identified in 
Enterococcus hirae and Bacillus subtilis. Subcellular cell fractionation experiment 
confirms that CupA harbors a single N-terminal membrane-spanning helix, thus is the 
first identified cell membrane-anchored copper chaperone. The membrane association 
may facilitate copper loading onto CupA as copper gets into the bacterial cell. Cell 
growth experiments reveal that a Cu(I)-binding competent, membrane-localized CupA is 
obligatory for bacterial copper resistance. The crystal structures of the soluble domain of 
vi 
 
CupA (sCupA) and N-terminal MBD of CopA (CopAMBD) in the Cu(I) bound state reveal 
isostructural cupredoxin-like folds each harboring a binuclear Cu(I) cluster 
unprecedented in bacterial copper trafficking. NMR studies reveal unidirectional Cu(I) 
transfer from the low-affinity site (S2 site) on sCupA to the high-affinity site (S1 site) of 
CopAMBD. NMR solution structure of apo-sCupA adopts the same fold as the crystal 
structure of Cu(I)-bound sCupA with the exception of a flexible Cu(I) binding loop 
between 7 and 8. Backbone and side chain NMR dynamic study show the side chains 
of residues in S1 site are pre-arranged for Cu(I) binding while side chains of residues in 
S2 site are completely disordered. Cell growth analysis shows that the high affinity S1 
Cu(I) site is dispensable for cellular Cu(I) resistance, while the low affinity S2 Cu(I) 
binding site is essential for bacterial growth under copper stress, which is in consistent 
with the hypothesis that S2 is more involved in Cu(I) transfer to CopA for efflux. All 
above establishes the first Cu(I) chaperone required for copper resistance in bacteria in 
contrast to the CopZ-like chaperones.   
The study in my dissertation leads to two further important questions which will 
require additional investigation. One is what the mechanism of a protein-protein 
interaction is between CupA and CopA and the second one is there any interplay between 
copper resistance and redox homeostasis systems in S. pneumoniae cells. The answers to 
those two questions may help us to better understand the biology of S. pneumoniae, 
which might shed light on combating the drug resistance issue of DRSP.  
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CHAPTER I: The functional role of copper in biology and of the host-pathogen 
interface 
1.1 Copper chemistry 
Streptococcus pneumoniae (S. pneumoniae) is a major bacterial pathogen in 
children and adults. It is normally a commensal bacteria for the upper respiratory tract of 
human and may invade other parts of human host under certain conditions. Depending on 
the infected tissues, pneumococcus can cause various diseases, from localized disease 
such as otitis media and sinusitis, to more serious cases like pneumonia and meningitis.1 
The health care cost for pneumococcus-related disease is tremendous and mostly comes 
from pneumococcus caused pneumonia. Drug resistance S. pneumoniae is another major 
cause of pneumococcus-related disease and is held responsible for causing more 7000 
deaths annually in the U.S (data from CDC).   
General mechanism of copper homeostasis systems from both prokaryotes and 
eukaryotes will be discussed in this chapter, serving as a foundation to introduce my 
work presented in the following chapters, which is focusing on studying copper 
homeostasis system in S. pneumoniae.  
Copper in biological systens can exist in either the reduced, cuprous or Cu(I) 
(3d10) state or the oxidized, cupric or Cu(II) (3d9) state.  The reduction potential of +150 
mV for the one-electron reduction of Cu(II) to Cu(I) reveals that Cu(I) is the major 
oxidation state of copper in the reducing environment of the cellular cytosol or cytoplams 
(≈–220 mV).2  Cu(I) is a soft acid while Cu(II) is borderline acid as classified by the Hard 
and Soft Acids and Bases (HSAB) principle.3  As such, the metal binding sites in copper-
utilizing or transporting proteins are formed primarily by cysteine, methionine and 
2 
 
histidine residues as first coordination shell ligands.  Cu(I) is relatively unique in 
biological systems in that it can adopt thermodynamically very stable complexes 
characterized by a low coordination number (n) of 2-4.  In contrast, Cu(II) adopts higher 
coordination number complexes, with n=4-6, with a preference for four-coordinate, 
distorted square planar complexes.  Cu(II) complexes are also thermodynamically stable, 
since Cu(II) sits at the apex of the Irving-Williams series of divalent cation-small 
molecule chelate complex stabilties.4,5 The abilities of copper to cycle between two 
oxidation states and  to form thermodynaically stable and ligand exchange labile 
coordination complexes establish the foundation for understanding copper transport, 
sensing, trafficking, and utilization in biological systems.  
1.2 Cellular copper toxicity 
The mechanism by which copper impacts cell viability is a subject of ongoing 
investigation and may well involve a combination of effects depending on the 
microenvironmental niche of the organism.  The original proposal posted protein and 
DNA damage caused by hydroxyl radical (OH•) derived by a Cu(I)-catalyzed Fenton 
reaction with hydrogen peroxide (H2O2) with concomitant formation of Cu(II); this 
reaction becomes then catalytic in the reducing milieu of the cytoplasm.6  Indeed, the 
analogous reaction driven by Fe(II) has long been known to damage DNA and cause cell 
death.7 Although exogenous H2O2 clearly potentiates the ability of copper to kill 
intracelllar bacterial pathogens within macrophages,8 low molecular weight thiols 
(LMWTs) such as glutathione will chelate any free copper, rendering it incapable of 
cycling between Cu(I) and Cu(II) states6 thus attenuating its capacity to perform Fenton-
like chemistry. As a result, the ability of Cu(I) to catalyze the Fenton reaction within the 
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bacterial cytoplasm seems increasing unlikely; in contrast, there is some evidence to 
suggest that copper-mediated hydroxyl radical formation occurs in the periplasm of E. 
coli and by extension other Gram (–) bacteria.6,9    
 
 
 
Figure 1: Identified mechanism of copper toxicity for bacterial cell.  
The primary target to date intracellularly is [Fe-S] cluster, an important co-factor 
for enzymes involved in important biological pathways. 11–13   
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More recent studies reveal that the exposed iron-sulfur clusters in metalloenzymes 
involved in branch-chain amino acid synthesis are primary targets of copper toxicity in E. 
coli (Fig. 1).10 Cu(I) can inactivate the enzymes by displacing the iron atoms from the 
cluster in a reaction that does not require molecular oxygen.  The displaced iron is then 
postulated to overload the cell and accelerate the Fe(II)-based Fenton chemistry if oxygen 
is present (Fig. 1).10  Similar mis-metallation by excess copper of Fe sites in other iron-
sulfur-containing enzymes has been demonstrated to occur in other bacteria affecting key 
metabolic pathways including glucose catabolism and heme biosynthesis (Fig. 1).11–13  
However, more work must be done to validate this model as a general mechanism of Cu 
toxicity, particularly in those organisms that lack iron-sulfur cluster-containing enzymes 
and in others, e.g., lactic acid bacteria and S. pneumoniae, that thrive under conditions of 
considerable hydrogen peroxide generation.14  
1.3 Copper uptake and trafficking in human cells 
A cartoon representation of copper transport and trafficking from outside of the 
vertebrate host cell, e.g., a macrophage, to a bacterial pathogen that has been engulfed by 
that macrophage is shown (Fig. 2).  In eukaryotes from yeast to mammalian cells, the 
acquisition of cellular copper requires a conserved plasma membrane-localized Cu(I) 
importer, Ctr1 (Fig. 3).15  In the extracellular space, free copper is in the oxidized Cu(II) 
state; thus, for Ctr1 to transport Cu(I) across the cell membrane, Cu(II) must be reduced 
to Cu(I) by yet unidentified Cu(II) reductase in humans (Fig. 2).  The mechanism by 
which human Ctr1 (hCtr1) transports Cu(I) has received considerable attention.  Since 
Ctr1 lacks an identifiable ATP-hydrolysis domain, Cu(I) transport is ATP-independent.16  
hCtr1 has three transmembrane (TM) domains and exists as a symmetrical all -helical 
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homotrimer in a native phospholipid bilayer17 with the proposed Cu(I) translocating 
channel in the center of the trimer (Fig. 3).  Four consecutive sets of methionine triads in 
the channel region contributed by residues from each monomer (Met43, Met45, Met150 
and Met154) are proposed to be involved in Cu(I) capture and shuttling.18  The fours 
triads span from the extracellular N-terminal “capture” domain to the transmembranous 
region.  The organization of the triads suggests a stepwise transport model of Cu(I) across 
the plasma membrane via transient “bind-and-release” mechansim mediated by ligand 
exchange by the methionine triads within the channel.18  The cytosolic C-terminus of 
Ctr1 harboring a His188-C189-H190 sequence has been shown to bind four Cu(I) as a 
Cu4L6 cuprous-thiolate polynuclear cluster19 and is thought to be required to facilitate 
Cu(I) transfer to downstream cellular Cu(I) binding proteins, but plays no role in the 
kinetics of Cu(I) permeation.20,21  
The copper trafficking hypothesis22 posits that there is no free copper present in 
the cytosol and that Cu(I) is shuttled to different cellular targets by dedicated Cu(I) 
chaperones. The human Cu(I) chaperone Atox1/HAH1 has been characterized as a small 
cytosolic protein with the ferredoxin-like fold and the conserved Cys-xx-Cys Cu(I) 
binding motif (where x stands for any residue).23,24  There are two models for Cu(I) 
loading onto Atox1 from Ctr1: (1) Atox1 receives Cu(I) from the Cu(I) binding sites in 
cytosolic C-terminal  domain of Ctr1 directly via specific protein-protein interaction20 or 
(2) glutathione functions as an intermediate between the cytosolic C-terminal domain of 
Ctr1 and Atox1 by receiving Cu(I) from Ctr1 and then delivering it to Atox125.  Both 
models assume that the Cu(I) chaperone is evenly distributed in the cytosol. Although 
Atox1 is constitutively expressed in S. cerevisiae and is present at ≈10 µM22, there is 
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some question as to how the cell ensures that Atox1 is capable of sequestering all Cu(I) 
as soon as it enters the cytosol.  Rather than a 3D-random search model, a recent study 
reveals that Atox1 can bind to liposomes, which function as mimic of plasma membrane, 
through interaction between the positively charged protein surface residues and the 
negatively charged moiety of the membrane in vitro26.  Association with the plasma 
membrane would signficantly reduce the 3D-random search to two-dimensional search 
along the inner leaflet of the plasma membrane, which would facilitate Atox1 Cu(I) 
loading. Consistent with this hypothesis, although the copper binding of the membrane-
binding deficient mutants of Atox1 remains the same in vitro, these mutants show 
decreased copper loading in vivo26.   
Identified targets for Cu(I) loaded Atox1 to transfer Cu(I) are Cu(I) transporting 
P1B-type ATPase ATP7A and ATP7B, which are primarily located in the trans-Golgi 
network (TGN). P1B-type ATPases transport metal ions, such as Cu(I) and Ag(I), across 
biological membranes.8 The mechanism of Cu(I) transport by P1B-type ATPase will be 
discussed in detail later. Upon reaching ATP7A and ATP7B, Cu(I) can be imported into 
TGN to be supplied to the maturation of different cuproproteins. Excess Cu(I) would 
cause the relocalization of ATP7A and ATP7B to intracellular vesicles. Cu(I) then can be 
exported out of the cytosol via vesicle-mediated fusion.  
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Figure 2: Pathways of copper transport, trafficking, sensing and resistance in several 
well-studied bacterial pathogens. 
These include the Gram (+) pathogen, S. pneumoniae, M. tuberculosis, and two 
similar Gram (–) pathogens, E. coli, and Salmonella spp., at the host-pathogen 
interface. CM, cell membrane; M, membrane; OM, bacterial outer membrane; IM, 
bacterial inner membrane.  E. coli CueO, plasmid-encoded PcoA and mycobacterial 
MmcO151 are multi-copper oxidases (MCOs).37  Both MmcO and an outer membrane 
channel MctB31 are required for mycobacterial copper resistance. CtpV is a copper 
exporting ATPase that is required for full virulence of M. turberculosis in murine 
models of infection.152 while Msp is a porin on the outer membrane of M. 
tuberculosis.153 Over-expression of Msp genes induces copper stress in M. 
turberculosis, consistent with a role in Cu uptake.153 The major components of 
bacterial copper homeostasis systems, including Cu(I) exporting P1B type ATPases, 
copper chaoerones, and  metalloregulatory proteins, are also shown (see text for 
details).1,46,48,56,154   
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Figure 3: Cartoon representation of the trimeric structure of hCtr1 derived from cryo-
electron microscopy reconstructions.17 
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1.4 The driving force for copper trafficking in cells  
Thermodynamic gradient is proposed to be the driving force for directing the 
copper flow in human cells, which is exemplified by the increasing Cu(I) binding 
affinities along the copper flow pathway. Several efforts have been made to measure the 
Cu(I) binding affinities of Atox1 and the metal binding domains (MBD) of ATP7A and 
ATP7B.27–29 MBD is the soluble, cytoplasmic domain of P1B-type ATPase, which shares 
structural similarity with the copper chaperones and is postulated to be involved in Cu(I) 
transport. Based on an electrospray ionization mass spectrometry (ESI-MS) approach27, 
Atox1 has lower affinity compared with MBDs of ATP7A, which is consistent with the 
thermodynamic gradient model. It should be noted that the Cu(I) binding affinities 
determined by ESI-MS are 3-4 magnitudes lower than the affinities determined by 
competition titration28,29. However, the general increasing trend of Cu(I) binding 
affinities along the pathway remains the same.  
1.5 Copper flow in the human host cell can be shifted towards phagolysosome  
A study using X-ray microprobe analysis has demonstrated that there is ~ 10 fold 
increase of Cu(I) within the mycobacteria-containing phagosomes in interferon- (IFN- 
stimulated macrophages30. Using RAW264.7 macrophage as a model, proinflammatory 
signals (IFN-and lipopolysaccharide from bacteria) induce the expression of IFN- in 
macrophages, stimulating Cu(I) uptake and the trafficking of ATP7A to vesicles 
overlapping with phagosomal compartments.8 The increased uptake of Cu(I) and 
relocation of ATP7A contribute to the accumulation Cu(I) in pathogen-containing 
phagosomes and the increased Cu(I) is proposed to facilitate bacterial killing through 
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copper toxicity mechanism that we have discussed. Indeed, copper resistance has been 
shown to be necessary for the virulence of mycobacteria31. To fight against the  
overloading of Cu(I), bacteria have to divert the copper flow out of their cellular 
environment through their copper homeostasis system.   
1.6 Copper homeostasis system in bacterial pathogens  
1.6.1 Most bacteria appear to lack a dedicated copper uptake system 
The copper importing mechanism for bacteria is largely unknown, with several 
isolated reports on potential candidates to be the copper importer. In the copper-requiring 
cyanobacterium Synechocystis PCC 6803, a P1B-type ATPase CtaA has been 
demonstrated to be responsible for copper uptake32. For Gram-negative bacteria, the work 
on CopABCD operon from Pseudomonas syringae indicates CopC, a periplasmic copper-
binding protein and CopD, a probable inner membrane protein, function together for 
copper uptake into cytosol33. CopC has been shown to have two distinct copper-binding 
sites: Cu(II) site and Cu(I) site, which are 30 Å apart and oxidation of Cu(I)-CopC or 
reduction of Cu(II)-CopC results in the translocation of copper to different site (Fig. 4). 34 
 For Gram-positive bacteria, the study on YcnJ protein from Bacillus subtilis 
suggests YcnJ may be involved in copper uptake.35 Sequence alignment reveals that the 
N-terminal region of YcnJ shares sequence similarity with CopC from P. syringae, with 
all the Cu(II) binding residues conserved and the C-terminal region shares similarity with 
CopD. Under extracellular copper deplete condition, an eight-fold up-regulation of ycnJ 
gene was observed and under extracellular copper replete condition, a 2-fold 
downregulation was observed.35 The ycnJ strain also shows growth phenotype in 
copper-limited growth media, revealing that YcnJ may well function in copper uptake. 
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Figure 4: Molecular structures of Cu(I)/Cu(II) bound CopC.  
Both copper sites are highlighted showing the coordination geometry for bound 
copper ions. 155 
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The lack of dedicated copper uptake system in most bacteria is consistent with the 
limited copper utilization in bacteria. The predicted copper-binding proteins accounts for 
less than 0.3% of the annotated proteome in bacteria.36 Of the few bacterial copper-
binding proteins, most of them are either localized in the periplasmic space in Gram-
negative bacteia, which is more oxidizing or are tethered to the plasma membrane and 
facing the extracellular space. For most human pathogens, copper may pose more as a 
threat than useful nutrition, especially in fighting against human host immune system as 
discussed above. The multi-level and well-regulated copper resistant systems to divert the 
copper flow out of bacterial cellular environment ensure the survival and virulence of the 
pathogens.  
1.6.2 Copper resistance determinant in the extracellular space of pathogens 
The extracellular space represents the dynamic environment in which bacterial 
cells reside. Bacteria secrete certain chelators into the extracellular space to lower free 
copper ion concentration before it reaches the bacterial cell. A copper binding 
siderophore, yersiniabactin (Ybt), with previously unappreciated superoxide dismutase-
like (SOD) activity has recently been characterized in uropathogenic E. coli (UPEC).37 
Yersiniabactin serves as a bacterial extracellular Cu(II) sequester by binding to Cu(II) 
and Cu(II)-Ybt has been demonstrated to have SOD-like activity while apo-Ybt has no 
such activity. The dual function of Ybt gives the bacteria survival advantage once they 
are internalized into macrophages, where they encounter a toxic cocktail of elevated 
copper and superoxide during the human immune response.8,38  
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Figure 5: Molecular structures of (a) Cu(I) and (b) Cu(II)-bound Candida albicans 
SOD5.39 
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In the most prevalent human fungal pathogen Candida albicans, a novel SOD has 
been characterized (SOD5) (Fig. 5).39 SOD5 from C.albicans represents a class of GPI- 
anchored extracellular SOD that is the Cu-only homologue to the classic Cu/Zn SODs. 
Structural studies on SOD5 have shown that although it retains the overall structure of 
Cu/Zn SODs, SOD5 is a monomeric copper protein lacking a zinc-binding site and the 
electrostatic loop proposed to function as superoxide guidance to catalyze the SOD 
activity (Fig. 5).39 Cell culture experiments of C. albicans have revealed SOD5 is 
secreted as disulfide-oxidized apo-protein and can be readily metallated by extracellular 
copper ion due to the solvent exposed copper site.39 Despite all the structural difference, 
the copper bound SOD5 has been shown to disproportionate superoxide with the kinetics 
similar to Cu/Zn SODs, approaching diffusion limits.39 The open copper site makes this 
class of SOD well adapted to the challenges of the increased copper level at the host-
pathogen interface. The bacterial homologous protein of SOD5 has not been identified, 
however, this might still be a strategy bacterial pathogens employ to fight against copper 
stress. 
1.6.3 Cu(I) Sensing in Bacteria 
The transcription and expression of the proteins involved in copper flow in 
bacteria are controlled by a group of proteins designated metalloregulators. Seven 
families of prokaryotic metalloregulator proteins have been characterized with distinct 
structural features as summarized in another review.40 Three other families are 
characterized with only a subset associated with metal sensing (TetR41,42, MarR43 and 
LysR44).  
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Figure 6: Molecular structures of two Cu(I)-specific metalloregulatory proteins.   
(a) Cu(I)-bound E. coli CueR;46 (b) Cu(I)-bound CsoR from Geobacillus 
thermodenitrificans.49 Protomers are differentially shaded with the Cu(I) binding sites 
circled and expanded (right). 
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There are no direct linkages between metals and the family of metalloregulators. The 
same family of metalloregulators has been shown to sense different metals while the 
same metal can be sensed by distinct family proteins. This is consistent with the “mix and 
match” approach in the evolution of metal sensing genes which could be mediated by 
horizontal gene transfer.45 There are several identified Cu(I)-responsive metalloregulator 
in bacteria, including CueR in E. coli, CopY in E. hirae and S. pneumoniae, and CsoR in 
M. tuberculosis and Geobacillus thermodenitrificans, respectively.1,46–49  
The interaction between Cu(I)-responsive metalloregulators and the cognate DNA 
serves as the basis in understanding metalloregulator mediated gene regulation. The 
different DNA-binding properties between Cu(I) and apo form of Cu(I)-responsive 
regulators are exploited to activate or repress the transcription of the downstream genes. 
CueR, the Cu(I)-responsive regulator in E.coli, binds to DNA with high affinity in both 
apo and Cu(I) states.46 In the apo form, CueR binds DNA, suppressing transcription. The 
Cu(I)-CueR binds and unwinds DNA, activating the transcription.50,51 There is no 
evidence that CueR undergoes a mechanism similar to the thiol ligand exchange process 
as observed for Cu(I) chaperones52 to facilitate the transition between apo and Cu(I) 
states. So the high Cu(I) binding affinity46 would pose a high energy barrier for the 
transition between apo and Cu(I) bound CueR, which is in contrast to the efficient 
regulation. The emerging field of applying single molecular technique to study the 
mechanism of protein-DNA interaction of CueR has provided one possible approach to 
switch off the transcription activation by replacing the incumbent Cu(I)-CueR  with apo-
CueR on the DNA.53  
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 Other than Cu(I) sensing in cytoplasm by Cu(I)-responsive regulators, Gram-
negative bacteria has to respond to elevated copper level in the periplasm and initiate 
transcriptional regulation of periplasmic copper resistance system (CueO54 and 
CusCBA55) in the cytoplasm. A CusRS two-component system was identified and has 
been demonstrated to be essential for the induction of the cusCFBA operon, including the 
periplasmic Cu(I) chaperone CusF (Fig. 7a).56 The histidine kinase CusS is predicted to 
be a membrane protein, with a periplasmic sensor domain. The sensor domain has been 
shown to bind Ag(I), which has similar chemical property as Cu(I), with micromolar 
affinity and the Ag(I) binding causes conformational change and dimerization of the 
sensor domain, which may be responsible for initiating the signal transduction across the 
cytoplasm membrane.56  
1.6.4 Cu buffering by low molecular weight thiols (LMWT) 
The tripeptide glutathione (GSH) is proposed to be one of the most abundant 
LMWT inside the bacterial cell with high affinity for Cu(I)27. Based on the high affinity 
for Cu(I) through the sulfhydryl group of the cysteine moiety, reduced glutathione (GSH) 
is proposed to form GSH:metal complex, which can effectively sequester toxic copper 
from the bulk cytosolic environment. In Gram-negative bacteria E. coli, the deletion of 
the glutathione synthesis machinery has no effect on the growth of cells under copper 
stress.57 Gram-positive bacteria have a different story. Based on genome sequence 
analysis, Streptococcus pneumoniae does not encode glutathione synthesis machinery and 
the major source of glutathione is imported from the environment facilitated by the ABC 
transporter substrate binding protein, GshT. The ∆gshT strain, which fails to accumulate 
cytosolic glutathione, shows severe growth defect under copper stress.58  
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1.6.5 CopZ-like Copper Chaperones 
CopZ from Enterococcus hirae is the first identified bacteria Cu(I) chaperone.59 
Structural studies reveal CopZ represents the bacterial Atox1-like copper chaperone with 
a ferrodoxin-like fold and conserved CXXC Cu(I) binding motif.60 In cyanobacteria, a 
Atox1-like copper chaperone scAtx1 has also been discovered. The CopZ and CopZ-like 
proteins represent one of the major classes of Cu(I) in bacteria. Although some data 
suggests CopZ may transfer Cu(I) to the copper responsive regulator CopY,59 the major 
function of CopZ-like chaperones is still proposed to be delivering Cu(I) to the exporting 
P1B-type ATPases.61  
 The copper coordination chemistry of CopZ-like Cu(I) chaperones receives 
special attention (Fig. 7b). NMR solution structures of  Bacillus subtilis CopZ suggest 
the S-Cu-S bond angle is ~ 120 °.60 That raises the question whether there is a third 
solvent ligand. EXAFS studies on Atox1/HAH1 suggest it is possible to reconstruct 
Cu(I)-HAH1 with a S-Cu-S bond angle ~ 180  ° in a buffer containing no thiol ligand.24 
In cyanobacteria, one extra histidine is also involved in the coordination of Cu(I).62,63 The 
low coordination number for Cu(I) is proposed to be important for copper transfer to 
happen between Cu(I) chaperones and metal binding domain (MBD) of copper 
transporting P1B-type ATPase. It should be noted that despite the proposed central role of 
CopZ-like chaperones in Cu(I) delivery to P1B-type ATPases, there is no experiment 
evidence in support of CopZ-like copper chaperone dependent protection against copper-
mediated cell damage, nor there is no copper sensitivity in any of the CopZ mutants 
under copper stress. 
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Figure 7: Structures of periplasmic Cu(I) chaperone CusF, Cu(I) chaperone CopZ,  
and the apo-structure of the Cu(I)-effluxing P1B-type ATPase CopA.  
(a) E.coli CusF, a periplasmic Cu(I) chaperone in the cusCFBA operon.  (b) B. 
subtilis CopZ, representative of the Atox1-like ferredoxin-like fold 
metallochaperones. (c) L. pneumophila CopA with the proposed copper entry, 
transmembrane (TM-MBS) and exit sites indicated.67,73 The MA and MB helices 
are shaded cyan, with the actuator (A, yellow), nucleotide-binding (N, magenta) and 
phosphorylated (P, green) domains also highlighted.  
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Figure 8: Cartoon of a mechanistic model of Cu(I) efflux across the bacterial inner 
membrane. 
This figure summarizes recent structural and biochemical studies on CopA from E. 
coli, A. fulgidus and L. pneumophila.  CopA is postulated to transport two Cu(I) 
ions per ATPase cycle.  E. coli CusF has been shown to be metallated upon Cu(I) 
release from CopA through a protein-protein interaction.77  
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1.6.6 Cu(I) delivery to P1B-type ATPase and Cu(I) transport across bacterial cell 
membrane 
The work on copper transfer from copper chaperone to P1B-type ATPase focuses 
primarily on the direct copper transfer between copper chaperone and the MBD of 
ATPase, the formation of the protein-protein complex and the ligand exchange transfer 
mechanism. The copper chaperone from cyanobacteria scAtx1 has been shown to form 
heterodimer with N-terminal MBD of PacS, the Cu(I) importing ATPase for thylakoid in 
a Cu(I) dependent manner.64 Further NMR studies identified a protein-protein complex 
formed by yeast copper chaperone Atx1 and MBD of CCC2a, with a dominant species 
being a Cu(I) tri-coordinated by cysteines from both proteins.52 This species is proposed 
to be the intermediate step for copper transfer, which establishes the ligand exchange 
model for protein-interaction-dependent Cu(I) transfer.  
The copper transporting P1B-ATPase is the most abundant P1B-ATPase65 and is 
recently classified into 1B-1 subclass of P1B-ATPase using combined bioinformatics and 
biochemical data66. The core structure of P1B-1 ATPase consists of 6 transmembrane 
helices (TM), designated M1-6, starting from N-terminus to C-terminus (Fig. 7c).67 The 
core -helix bundle usually has two flanking N-terminal TMs (MA and MB) that are 
specific of the P1B-1 ATPase class and one or several N- and/or C-terminal metal binding 
domains (MBD).  A conserved Cys-Pro-Cys (CPC) motif in TM459,68 is proposed to be 
involved in copper binding. The proposed general mechanism for P-type ATPase is based 
on the Albers-Post model (Fig. 8).69,70 The E1 state of the enzyme has high affinity for 
substrate and marks the beginning of copper transporting cycle. ATP binding and 
hydrolysis results in substrate bound phosphoenzyme intermediate E1P and subsequent 
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E2P state. During E2P state, substrate is released to the extracellular space. The enzyme 
is then cycled back through E2 state to E1 state.71  
 Most of the work on P1B-1 ATPase has been carried out using Archaeoglobus 
fulgidus CopA (AfCopA) and Legionella pneumophila CopA (LpCopA).  The first high 
resolution x-ray crystallographic structure of metal-free apo Lp CopA has been used to 
model a candidate copper transport pathway within the transmembrane domain of CopA 
(Fig. 8).67 This Cu(I)-translocation pathway is proposed to involve three spatially 
resolved Cu(I) binding sites termed entry, transmembrane and exit.  The entry site is the 
first site that Cu(I) might encounter and consists of the conserved residues M148, E205 
and D337 (Fig. 7c). The entry site is butressed by a cluster of positively charged residues, 
which constitute a platform helix as part of the linked P1B-specific MB helix. The 
positively charged platform is believed to provide the docking site for the electronegative 
surface of the N-terminal MBD or the cognate copper chaperone dictated by charge 
complementarity.  The MB helix has a pronounced kink induced by two consecutive and 
highly conserved Gly residues, G129 and G130 in Lp CsopA, with the C-terminal region 
of the MB helix hosting three of the positively charged residues of the platform.67  
 The mechanistic importance of the proposed copper entry site and the positive 
charge of the platform helix has been experimentally tested in Af CopA.72 Af CopA 
exhibits approximately 50% amino acid similarity with the Lp CopA and the proposed 
copper entry site and docking platform are conserved.  The copper chaperone Af CopZ 
contains a predicted electronegative patch which is complementary to the positively 
charged platform on Af CopA as judged by a homology model of Af CopA based on the 
structure of Lp CopA. Three major groups of mutations were characterized: (1) mutations 
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in the kink region of the MB helix designed to alter the local structure of the platform 
helix (kink mutant); (2) mutations designed to eliminate the positively charged residues 
in the platform (charge mutant) and (3) mutations to replace the coordination residues of 
the copper entry site (coordination mutant).  If free Cu(I) is utilized as the copper donor 
(which is highly unlikely in the cytoplasmic environment) there is no observed difference 
in the kinetics of Cu(I)-stimulated ATP hydrolysis between among three mutants and the 
wild-type enzyme in vitro.  This suggests that the platform and copper entry site are not 
required for chaperone-independent copper delivery to CopA. However, if Cu(I)-Af CopZ 
was used as copper donor, both the charge mutant and the MBS entry site mutant result in 
a loss of Cu(I)-stimulated ATPase activity.  In striking contrast, the kink mutant has no 
impact on ATP hydrolysis.  This latter observation is interesting because this Gly-Gly 
sequence is the site of a number of Menkes and Wilsons disease-causing mutations in 
ATP7A and ATP7B, respectively. That might suggest that the kinked MB helix is 
required for the structural integrity of the transporter in cells or otherwise attenuates 
metal transport rates via uncoupling of ATP hydrolysis and metal efflux, which is not 
typically measured in these assays.  An analogous charge substitution mutant of Af CopZ 
in which candidate negatively charged residues predicted to physically interact with the 
platform helix were mutated to postively charged residues shows the same degree of 
attenuation in ATPase activity as the charge mutant of Af CopA.  These data taken 
collectively are strongly consistent with the charge complementation model of Cu(I) 
chaperone-mediated Cu(I) transfer to CopA and might suggest that the local structure is 
of comparatively lesser importance in ATPase stimulation.  Given the high Cu(I) binding 
affinity of copper chaperones, the copper is postulated to transfer from the chaperone to 
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the entry site via a mechanism similar to the proposed ligand exchange model.52   
However, further studies are required to obtain coordination chemistry details on the 
transfer process and there is as yet no evidence for a Cu(I)-trapped CopZ-CopA complex, 
a presumed intermediate on the Cu(I)-transfer pathway.  
 The binding of copper at the copper entry site of CopA is proposed to be 
transient.67,73  Copper would be further delivered to the high affinity transmembrane 
copper binding site (TM-MBS).74  The first report on the TM-MBS of AfCopA proposed 
two sites, both with femtomolar copper binding affinity.74  Based on EXAFS, site I 
contains two cysteine residues from the conserved CPC motif in M4 helix and the 
tyrosine residue from the conserved IYNV motif in M5 helix. Site II is rather unique, 
formed by one asparagine residue from M5 helix and methionine and serine residues in 
M6 helix. The structural and further molecular dynamics (MD) studies give us a much 
deeper understanding of the TM-MBS.67,73  Four of the six coordinating residues 
proposed based on Af CopA data were found to be positioned in the putative site I and II 
in the first crystal structure of the Lp CopA67 while the tyrosine and asparagine residues 
from M5 helix require side-chain rearrangement to be close to the putative sites. Based 
on MD simulation, the site I formed by the two cysteine residues Cys382 and Cys384 
from the CPC motif may be more important in transporting copper.73  
 The high affinity of TM-MBS for copper poses an energy barrier for releasing 
copper into the extracellular bulk solvent.74 The presence of a putative Cu(I) exit site 
involving conserved glutamate and methionine residues may facilitate the copper release 
(Fig. 7c).  Based on MD simulations of the Lp CopA structure, extracellular solvent was 
observed entering the TM domains from the periplasmic side. Solvent reaches the Glu189 
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in the exit site, outlining a putative Cu(I) release pathway.  This solvent filled pathway is 
predicted to be wide enough for copper ion to be delivered from TM-MBS to the exit site. 
The Cys382 and Met717 residue from TM-MBS are found to be along the solvating 
channel and are proposed to be important in shuttling copper ion to the exit site. One 
conserved Pro residue involved in the structural rearrangement of MA and M5 helices is 
predicted to be important for the opening of the release pathway to the extracellular 
space.  All the residues proposed based on MD simulation were tested by both in vitro 
ATPase activity assay and in vivo complementation of LpCopA into CopA deficient E. 
coli.  Substitution of the Met in the TM-MBS and the Pro involved in the structural 
rearrangement are found to be detrimental in both types of experiments while mutations 
on other residues only show significant effects only in the in vitro experiment, which may 
be traced to the redundancy of the copper resistance system in E. coli.  
1.6.7 Cu(I) delivery to the HME-RND complex by periplasmic Cu(I) chaperones and 
Cu(I) transporting to the extracellular space through heavy metal resistance-
nodulation-cell division (HME-RND) complex 
 The periplasmic space in Gram-negative bacteria is a more oxidizing environment 
compared to the cytosolic space. The deletion of periplasmic copper resistance protein 
CusF has been shown to result in a more copper sensitive phenotype.75 Structural and 
spectroscopic studies on CusF reveal a methionine rich copper site, which consists of two 
methionine residues, one histidine residue and the site is stabilized by cation-π interaction 
with a nearby tryptophan residue (Fig. 7a).76 Recent evidence suggests that CusF gets 
Cu(I) loaded through interaction with cytosolic membrane copper exporting P1B-type 
ATPase CopA were reported. The Cu(I) transfer from CopA to CusF has been shown to 
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be unidirectional and dependent upon the ATP hydrolysis. The transfer requires specific 
protein-protein interaction between CopA and CusF, since the replacement of either 
component by CusFs from other species results in undetectable Cu(I) transfer. Through 
immunoprecipitation experiments, the authors reveal preferred interaction between Cu(I)-
CopA with apo-CusF when holo-CopA is in the E1.Cu(I) form, which is consistent with 
the model of Cu(I) movement during the CopA ATPase cycle.77 Metallated CusF has 
been shown to deliver copper to CusB in the CusCBA HME-RND complex through 
specific protein-protein interaction with CusB.78 Although the in vitro data suggests the 
Cu(I) transfer occurs in both direction between CusF and CusB and is distributed equally 
between these two proteins, it is possible the equilibrium would be shifted by 
translocating Cu(I) to the extracellular space by CusCBA complex as a whole and the net 
flow of Cu(I) is towards the extracellular space.79  
 CusCBA is a tripartite complex that spans both inner and outer membrane, which 
consists of CusA, a RND efflux pump, CusB, a periplasmic membrane fusion protein 
(MFP) and CusC, an outer membrane channel protein, with a 3:6:3 polypeptide ratio 
(Fig. 2).80,81  The crystal structure of CusA suggests CusA exists as a homodimer and 
each monomer contains 12 TM helices and a periplasmic domain formed by two loops. A 
three methionine residues cluster (Met573, Met623 and Met672) is proposed to be the 
Cu(I) binding site receiving Cu(I) from periplasmic CusB protein, which may be 
delivered by CusF as discussed above. A more recent tri-element X-ray absorption 
spectroscopy (XAS) study exploiting protein-specific selenomethione labeling and Se, 
Ag and Cu XAS suggests that Cu(I)-CusB activates Cu(I) transfer from CusF to CusA 
into novel S2(O/N) Cu(I) site formed by two Met and one Glu.82  CusA, CusB and CusF 
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continue the theme of Met-rich Cu(I) coordination complexes in the more oxidizing 
periplasm as they are less susceptible to oxidation than the Cys-rich coordination sites 
that dominate in the cytoplasm.82 There are two methionine residues (Met271 and 
Met755) in the periplasmic domain together with 3 pairs of methionine residues in the 
TM domain (Met391 and Met1009, Met486 and Met403, Met410 and M501) forming a 
potential copper ion relay network83 to transport copper in a stepwise fashion. The 
existence of a periplasmic copper binding site and the spanning of the methionine relay 
network make it tempting to propose CusA transport the copper ion from both the 
cytoplasm and periplasm to the outer membrane channel for exporting.54 The 
electronegative channel formed by CusB and CusC may facilitate copper export through 
negative potential gradient.83  
1.7 Scope of dissertation research 
Since the original discovery of Atx-1 like copper chaperone in 1999, there is 
considerable amount of work dedicated to characterize the copper chaperone and the 
copper transfer between copper chaperones and cellular metalloproteins or Cu(I) 
transporting P1B type ATPase. Despite these progresses, it remains unclear the functional 
role of copper chaperone in bacterial cells. This is exacerbated by the fact that Atx-1 like 
copper chaperones are not obligatory for copper resistance in known organisms.  
The two major questions that the work presented in this dissertation is designed to 
address are: (1) What is the molecular mechanism of copper resistance in bacterial 
pathogens to prevent copper overdose by human host? and (2) what is the functional role 
of copper chaperone in copper resistance system in bacteria? Studies are focused on the 
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novel copper chaperone protein CupA discovered in S. pneumoniae, which has not been 
found prior to this work.  
 In chapter II, efforts were made to characterize CupA from S. pneumoniae. CupA 
was characterized to be a novel membrane-anchored copper chaperone. The Cu(I) 
binding affinities and membrane localization of CupA are essential for the survival of 
bacterial cells under copper stress. In Chapter III, NMR solution structure of apo-sCupA 
and NMR dynamic studies revealed a flexible Cu(I) binding loop in CupA. S2 Cu(I) 
binding site in CupA was shown to be essential for copper resistance. In chapter IV, 
studies on the transcriptional regulator CopY were presented. Chapter V focuses on the 
future directions followed by the work discussed in previous chapters.  
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CHAPTER II: CupA is a novel Cu(I) chaperone in S. pneumoniae 
2.1 Introduction  
For S. pneumoniae to survive and cause disease in different host environments, it 
has to adapt to various conditions in the environments, including extracellular metal ion 
concentration. The concept of “nutritional immunity”84 refers to host withholds essential 
metal, such as Fe and Zn, away from engulfed pathogens in the macrophages. Contrary to 
this, elevated Cu has been linked to efficient pathogen removal in macrophages. Thus, the 
bacterial metal homeostasis systems might serve as novel drug targets for combating 
drug-resistant pathogens with demonstrated examples from Salmonella.85 S. pneumoniae 
has no known copper containing proteins, thus it is crucial for the bacterial cells to deal 
with copper toxicity. Copper resistance in S. pneumoniae is mediated by a single operon 
encoding the winged helix Cu(I)-dependent repressor, CopY86, CupA,,of unknown 
function prior to this thesis work, and Cu(I)-effluxing P1B-type ATPase CopA.1 S. 
pneumoniae also encodes the TIM-barrel Cu(I)-binding protein CutC87 previously shown 
to play a role in copper homeostasis in Enterococcus faecalis88, but its expression is not 
induced by Cu in Spn1.  Spn CopY is functionally equivalent to Enterococcus hirae 
CopY89 and performs the role played by the copper metalloregulatory protein CsoR and 
CsoR-like regulators found in other Gram-positive human pathogens including M. 
tuberculosis48,90, S. aureus91 and Listeria monocytogenes92.  Although the intracellular 
requirement for Cu(I) in S. pneumoniae is unknown93, S. pneumoniae contains significant 
cell-associated copper94, and adaptation to a high Cu(I) environment may be important 
for invasive disease.  Total Cu(I) is replete in the nasopharynx and in lung tissues and 
copA expression is induced in S. pneumoniae residing in these tissues in intranasally 
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infected mice1.  Deletion of copA leads to poor kinetics of colonization in the 
nasopharynx and delayed appearance and reduced bacterial loads in the lung1; consistent 
with this, signature-tagged mutagenesis reveals that strains inactivated in cupA and copA 
are attenuated in a murine model of lung infection and pneumonia95. 
However, the function of CupA was still unknown prior to this thesis work. In this 
chapter, a structurally novel copper chaperone-copper effluxer pair jointly mediates 
resistance to copper toxicity was characterized in S. pneumoniae D39 strain.  CupA is a 
plasma membrane-anchored copper binding protein whose membrane localization and 
high Cu(I) binding affinity are required for cellular copper resistance.  The 
crystallographic structures of sCupA and CopAMBD reveal a new functional twist on the 
common cupredoxin fold firmly associated with iron uptake in yeast and cytochrome c 
oxidase assembly and electron transfer.96–98  Although I establish that the soluble domain 
of CupA (sCupA) is capable of transferring bound Cu(I) to N-terminal metal binding 
domain of CopA (CopAMBD) in a thermodynamically favorable and kinetically facile 
reaction, the Cu(I) transfer between CupA and CopAMBD is not required for cellular 
copper resistance under conditions of acute copper stress.  These data suggest that the 
primary function of membrane anchored CupA under these conditions is to chelate Cu(I) 
as soon as it enters the cytoplasm, rather than function as an obligatory chaperone to the 
MBD of CopA.   
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2.2 Methods 
2.2.1 Bioinformatics analysis  
The protein sequence of CupA from pneumococcus was subject to protein-
BLAST search in NCBI. The multiple sequence alignment of CupA homologs from 
different bacteria were done using ClustalW algorithm.  
2.2.2 Protein expression and purification  
The pHis plasmid99 was used to subclone sCupA (residues 29-123 of full-length 
CupA) and the CopAMBD (residues 1-99 of CopA).  This vector encodes a His6 tag and 
TEV protease cleavage site at the N terminus to yield, following cleavage, three non-
native N-terminal amino acids of the sequence GAM for sCupA (denoted residues 26-28 
in the structure) and a single non-native N-terminal Gly in the case of 
CopAMBD(denoted Gly0).  BL21 (DE3) competent cells were transformed with the 
resultant plasmids.  For unlabeled proteins, an overnight culture of E. coli. cells was 
inoculated into Luria Broth (LB) media containing 100 μg/mL ampicillin. For the 15N/13C 
labeled proteins, an overnight culture of E .coli. cells was inoculated into M9 minimal 
media (pH 7.4) containing 100 μg/mL ampicillin, supplemented with 15NH4Cl (1 g/L) 
(Cambridge Isotope Laboratories) and [13C6]-D-glucose (2.5 g/L) (Cambridge Isotope 
Laboratories). For both media, the cells were grown at 37 °C to OD600 = 0.6. Isopropyl 
β-d-thiogalactopyranoside (IPTG) was then added to a final concentration of 0.4 mM and 
cultures were continued at 16 °C for 20 h.  The cells were harvested by centrifuging and 
kept at -80 °C.  All the buffers in the purification were degassed and refilled with Argon 
using a Schlenk line right before use.  To break the cells, the cells were resuspended in 
buffer R (25 mM Tris, pH 8.0, 200 mM NaCl, 5 mM TCEP).  The resuspended cells were 
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lyzed by a sonic dismembrator (Fisher).  The recombinant proteins were purified using 
HisTrap FF columns (GE Healthcare) using a gradient of imidazole from 10 mM to 300 
mM in buffer R.  The appropriate fractions were pooled and subjected to TEV protease 
cleavage at for 16 °C for 36 h. The proteins were further purified using HisTrap FF 
columns (GE healthcare) and Superdex 75 16/60 column (GE healthcare).  The purity of 
the proteins was estimated to be >95 % as judged by SDS-PAGE and ESI-MS.  Protein 
concentration was determined by A280 with an extinction coefficient of 4595 M-1cm-1 on 
an UV-visible spectrometer (HP/Agilent8453).  The number of reduced thiols was 1.9 for 
sCupA and 1.7 for CopAMBD (both expected to be 2.0) as determined by anaerobic DTNB 
colorimetric assay. Mutants of sCupA and CopAMBD were generated using site-directed 
mutagenesis strategy (Stratagene), and mutant proteins were purified similarly. 
2.2.3 Cu(I) form Protein crystallization  
Cu(I)-sCupA was crystallized by hanging drop vapor diffusion at 20 °C against a well 
buffer of 30 % (w/v) PEG 3350, 0.1 M sodium citrate tribasic dihydrate pH 5.0 and Big 
CHAP Deoxy. Cryosolvent was prepared by using 35 % (w/v) polyethylene glycerol 
3350 in the well solution. Cu(I)-CopAMBD was crystallized by hanging drop vapor 
diffusion at 20 °C against a well buffer of 28 % (w/v) polyethylene glycerol monomethyl 
ether 2000, 0.1M Bis-Tris pH 6.5. Cryosolvent was prepared by using 35 % (w/v) 
polyethylene glycerol monomethyl ether 2000 in the well solution.  
2.2.4 X-ray data collection, structure determination and refinement  
For CopAMBD, diffraction data for the native data set were collected at -160 °C on 
an R-AXIS IV+ detector at Indiana University, Bloomington. The space group of the 
crystal was P212121 with one monomer in the asymmetric unit. All data were processed 
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with the program HKL2000100.  Diffraction data for the initial phase determination were 
collected on ALS 4.2.2 (Advance Light Source, Lawrence Berkley National Lab).  
Initial phases for the structure of CopAMBD were determined by single-wavelength 
anomalous dispersion (SAD) techniques from a dataset collected on ALS 4.2.2 source 
with Cu(I) as the heavy atom. The structure of CopAMBD was solved and auto-built with 
PHENIX101. Two Cu(I) atoms were found in the structure. Iterative rounds of model 
building and refinement were carried out in Coot102 and PHENIX, respectively.  
For sCupA, diffraction data were collected at -160 °C on an R-AXIS IV+ detector 
at Indiana University Bloomington. The space group of the crystal was P21212 with one 
monomer in the asymmetric unit. All data were processed with the program HKL2000.   
Initial phases for the structure of sCupA were determined by using a portion of 
the crystal structure of CopAMBD as molecular replacement search model in PHENIX. 
The structure of sCupA was solved and auto-built with PHENIX. Two Cu(I) atoms were 
found in the structure. Iterative rounds of model building and refinement were carried out 
in Coot and PHENIX, respectively. Atomic coordinates and structure factors have been 
deposited to the Protein Data Bank with accession codes: sCupA (4F2E) and CopAMBD 
(4F2F). All structure related figures were prepared using PyMOL (Delano Scientific).  
2.2.5 Apo-sCupA backbone and side chain resonances assignments 
Typical NMR sample solution conditions were 300-600 μM, 15N/13C-labeled 
sCupA, pH 6.0, 50 mM sodium phosphate, 50 mM NaCl, 0.02% (w/v) NaN3 and 10% 
(v/v) 2H2O. All the NMR samples were prepared in an anaerobic glove box. Apo-sCupA 
was prepared with 5 mM TCEP. Varian DDR 800 and 600 MHz spectrometers equipped 
with cryogenic probes in the METACyt Biomolecular NMR Laboratory were used to 
34 
 
acquire data for sCupA samples at 298 K.  NMR spectra were referenced to H2O.  NMR 
data were processed using NMRPipe103 and was analyzed using Sparky104 and CcpNmr 
Analysis105. Chemical shift is referenced relative to 2,2-dimethyl-2-silapentene-5-sulfonic 
acid (DSS). Sequential resonance assignments of apo-sCupA were obtained using 1H-15N 
heteronuclear single quantum coherence (HSQC), HADAMAC106, along with triple 
resonance CBCA(CO)NH, CBCANH, HNCO and Best-HNCA107 spectra. Automatically 
backbone assignment server PINE108 was employed to help with the assignment. 
Assignments of side chain resonances were made using three-dimensional C(CO)NH-
TOCSY109, H(CCO)NH-TOCSY109,110, HCCH-TOCSY111 and HCCH-COSY112 
experiments. 
2.2.6 ICP-MS analysis  
1.5 mL aliquots of S. pneumoniae strains were centrifuged and washed once with 
BHI containing 1 mM nitrilotriacetic acid (Aldrich), then twice with PBS that had been 
treated overnight with Chelex-100 (Biorad) according to the manufacturer’s protocol. 
The cell pellets were dried overnight in a rotary evaporator.  400 μL of 2.5% v/v nitric 
acid (Ultrapure, Sigma- Aldrich) containing 0.1% v/v Triton-X 100 was added to 
solubilize the cell pellets which were then lysed for 10 min at 95 ºC with shaking at 500 
rpm followed by vigorous vortexing for 20 s.  200 μL of the lysed cell solution 
(equivalent to 0.75 mL total cell culture) was added to 2.8 mL of 2.5% v/v nitric acid for 
ICP-MS analysis.  Analyses were performed using a Perkin Elmer ELAN DRCII ICP-MS 
essentially as described earlier.94 The instrument was equipped with a Microflow PFA-ST 
concentric nebulizer with a 100 μL/min self-aspiration capillary, a cyclonic spray 
chamber, a quartz torch and nickel sampler/skimmer cones.  Germanium at 50 ppb was 
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added as an internal standard using an EzyFit glass mixing chamber.  Metal concentration 
per mg protein were determined in the following way.  ICP-MS gave [metal] in μg/L * 
0.003 L sample equals total μg metal in 0.75 mL of cell culture.  The μg metal * 1000 * 2 
gave the ng metal in the original 1.5 mL of culture.  Protein samples were resuspended in 
100 μL buffer and concentrations were determined in mg/mL using a Bradford assay 
(Biorad).  Total protein in 1.5 mL was calculated multiplying by 0.1 to correct for the 
resuspension volume.  The final copper concentration as expressed by ng metal/mg 
protein determined by dividing those two values (ng/1.5 mL)/(mg/1.5 mL) = ng/mg 
protein. 
2.2.7 Cu(I) Binding Affinity Measurements 
Bathocuproine disulfonate (BCS) and bicinchoninic acid (BCA) were used for 
Cu(I) binding affinity determination of sCupA and CopAMBD. All proteins for binding 
experiments were buffer exchanged from protein stock to the degassed buffer B (25 mM 
HEPES, pH 7.0, 200 mM NaCl) in an anaerobic glove box.  Cu(I) stock was prepared by 
taking the supernatant from the mixture of  CuCl powder with fully degassed buffer B 
(25 mM HEPES, pH 7.0, 200 mM NaCl). The accurate concentration of Cu(I) stock was 
determined by Atomic Absorption Spectroscopy with a general concentration around 10 
mM. The final titration solution contained 20 or 30 μM sCupA or CopAMBD and 30 or 40 
μM BCA (BCS) in Buffer B. Each 120 μL aliquot of titration solution was mixed with 
increasing Cu(I) titrant.  Optical spectra of BCA or BCS were recorded from 200 nm to 
900 nm. Corrected spectra were obtained by subtracting apo-sCupA (CopAMBD) spectrum 
from each Cu(I)-addition spectrum and then corrected for dilution. A483 was used to 
determine the concentration of Cu2-BCS complex with an extinction coefficient of 13500 
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M-1cm-1.  A562 was used to determine the concentration of Cu2-BCA complex with an 
extinction coefficient of 7700 M-1cm-1.  All the data were fitted to the appropriate 
competition model using Dynafit113.  The Cu(I) concentration of all Cu(I) titrants used in 
individual experiments was quantified by atomic absorption spectroscopy on a Perkin 
Elmer AAS-400 instrument.  
2.2.8 Western blotting to quantitate cellular expression levels of CupA and CopA in 
various cupA or copA mutants  
Whole cell lysates were prepared from strains IU1781 (D39 non-FLAG negative 
control), IU6041 (cupA-(C)-FLAG), IU6216 (∆cupA-(33-aa remnant)-(C)-FLAG)), 
IU6086 (cupA (∆(2-28)-(C)-FLAG), IU6215 (cupA (C74S,3A)-(C)-FLAG), IU6210 
(cupA (C74S)-(C)-FLAG) and IU6212 (cupA (3A)-(C)-FLAG).  To detect CopA-FLAG 
alleles, whole cell lysates were prepared from stains IU1781 (D39 non-FLAG negative 
control), IU6044 (copA (C)-FLAG), IU6260 (∆copA (C)-FLAG), IU6245 (copA (C49S)-
(C)-FLAG), IU6240 (copA (D442A)-(C)-FLAG), IU6307 (cupA (C74S)-copA (C)-
FLAG), and IU6308 (∆cupA-copA (C)-FLAG).  In order to obtain sufficient cell mass to 
prepare lysates with the FastPrep method, cell cultures were grown overnight in BHI and 
then diluted to 0.0035 (cupA (C)-FLAG and WT, as well as copA (C)-FLAG and copA 
(C49S)-(C)-FLAG) or 0.005 (all other mutant strains) in 30 mL BHI, and allowed to 
grow to an OD620 of 0.04 (cupA (C)-FLAG and WT, as well as copA (C)-FLAG and copA 
(C49S)-(C)-FLAG) or 0.06 (all other strains) or ≈3 doublings, at which time CuSO4 was 
added to a final concentration of 0.2 mM.  2.5 h after addition of Cu, at an OD620 of ≈0.25 
for cupA-FLAG strains (≈2 doublings for Cu-sensitive mutant alleles and ≈3 doublings 
for WT and cupA (C)-FLAG) and at an OD620 of ≈0.5 for copA-FLAG strains (≈2 
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doublings for Cu-sensitive mutant alleles and ≈3 doublings for WT, copA (C)-FLAG and 
copA (C49S)-(C)-FLAG), cells were centrifuged at 14,500 x g for 5 min at 4 °C in a 
chilled rotor. Supernatants were removed and pellets were placed on ice and suspended in 
1.0 mL of cold 20 mM Tris pH 7.0 and 8 μL of protease inhibitor cocktail set III 
(Calbiochem) and transferred to chilled Lysing Matrix B tubes (MP Biomedicals).  
Matrix tubes were secured in a 24 x 2 mL-tube adapter in a FastPrep-24 instrument (MP 
Biomedicals) stored at 4 ºC.  Cells were disrupted by three consecutive runs of 40 sec 
each at a speed setting = 6.0 m/s.  Lysed cell mixtures were placed on ice and centrifuged 
at 10,000 x g for 1 min at 4 ºC.  100 μL of supernatant was transferred to a tube 
containing 100 μL of cold 2x Laemmli sample buffer (containing 5% (vol/vol) of freshly 
added β-mercaptoethanol), boiled for 5 min and placed on ice.  Gel loading volumes were 
calculated to adjust for the slightly different cell culture densities so that the equivalence 
of 200 µL (cupA-FLAG strains) or 312 µL (copA-FLAG strains) of OD620 = 0.2 culture 
of each sample (corresponding to 16 and 25 µL of the final lysates for CupA and CopA 
strains, respectively) was loaded on each lane of a 15% (cupA-FLAG strains) or 10% 
(copA-FLAG strains) SDS-PAGE gel.  Visualization and relative quantitation of FLAG-
tagged proteins were achieved with Western blotting with primary anti-FLAG polyclonal 
antibody (Sigma, F7425) and an IVIS imaging system as described1. 
2.3 Results 
2.3.1 Both CupA and CopA are required for Cu resistance and localize to the 
plasma membrane  
Although the core domain of CopA looks to be a prototypical bacterial Cu(I)-
effluxing CopA of known structure that is evolutionarily related to Menkes and Wilson’s 
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disease copper transporters ATPA and ATP7B67, an approximate 100 residue domain that 
exhibits high sequence similarity to CupA is found at the N-terminus of CopA.  Notably, 
both domains contain a number of conserved cysteines and methionines that are excellent 
candidate ligands for Cu(I) and are found in a Cys….Cys-x-Met-x-Met (where x, any 
amino acid) primary structural arrangement (Fig. 9). Furthermore, the N-terminus of 
CupA is predicted to contain a single transmembrane helix between residues 5-22.  The 
high sequence similarity of CupA and the N-terminal region of CopA is a hallmark of a 
cognate copper chaperone-metal binding domain (MBD) pair found in many other 
bacterial species.114 S. pneumoniae does not encode an Atx1 or a CopZ and a 
bioinformatics analysis reveals that CupA is nearly always found in genomes that lack a 
recognizable gene encoding CopZ or Atx1.  Furthermore, CupA is widely distributed, 
perhaps more so that of CopZ/Atx1, but clearly clustered in Lactobacillus and 
Streptococcus; CupA is also present on at least one extrachromosomal plasmid pCT0018 
in Listeria monocytogenes (Fig. 10). 
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Figure 9: Multiple sequence alignment of CupA homologs. 
(a) S. pneumoniae D39 CupA (SPD_0634) with the N-terminal 99 residues of CopA 
(SPD_0635) and (b) putative CupAs from a number of bacterial sources illustrates 
conservation of a putative transmembrane domain (underlined) and candidate Cu(I)-
binding ligands (asterisks). 
 
40 
 
 
 
Figure 10: Phylogenetic reach of the putative copper chaperone CupA. 
Shown here is the distribution of CupA relative to previously structurally characterized 
bacterial chaperones, B. subtilis CopZ and Synechocystis Atx1 as of 2012. Each 
sequence was used to pBLAST a bacterial genome collection, and those sequences with 
≥70% identity with C…CxMxM (where x is any amino acid) sequence conserved are 
shown.  Indicated criteria for CopZ and scAtx1 are also shown, with the total number of 
nonredundant sequences meeting these criteria indicated.  
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 All CupAs are predicted to harbor a single transmembrane helix that anchors 
CupA to the plasma membrane.  To test this, we created ∆cupA and ∆copA Spn D39 
deletion strains and tested growth on a rich (BHI) medium under microaerophilic 
conditions in the presence of 0.2 or 0.5 mM added Cu(II) (see Appendix IV for strain 
details).  Both strains show a marked growth inhibition phenotype relative to the wild-
type strain (Fig. 11a and Fig. 12a-b), which can be rescued by ectopic expression of 
CupA from a heterologous promoter positioned elsewhere in the chromosome (Fig. 11b).  
This result rules out any unintended polar effect on the expression of the downstream 
copA gene due to deletion of cupA; in fact, the ∆cupA strain accumulates CopA protein to 
high levels (Fig. 13b).  Strains expressing C-terminally FLAG-tagged CupA or CopA are 
characterized by a wild-type growth in the presence of 0.2 or 0.5 mM Cu (Fig. 12c-d).  In 
contrast, a strain expressing a D442A CopA in which the predicted catalytic Asp residue 
in the ATPase domain of the CopA transporter (based on a structural alignment with 
Legionella CopA) is replaced with Ala, is indistinguishable from the ∆copA strain (Fig. 
12d).  More importantly, a strain expressing CupA lacking the N-terminal 
transmembrane domain, ∆(2-28) CupA (denoted hereafter sCupA), i.e., cupA(∆(2-28)) or 
cupA(∆(2-28)-(C)-FLAG) (Fig. 11c), is also unable to grow under these conditions.  
These experiments establish that a C-terminal FLAG-tag does not interfere with CupA 
and CopA function thus allowing us to determine the subcellular localization of both 
CopA and CupA using a standard fractionation scheme followed by Western blotting 
with anti-FLAG antibody (Fig. 14). These data reveal that both CupA and CopA localize 
exclusively to the plasma membrane in S. pneumoniae D39; furthermore, plasma 
membrane localization of CupA is required for full copper resistance.   
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Figure 11:  ∆cupA and ∆copA Spn strains are highly sensitive to copper toxicity. 
(a) which can be reversed by expression of cupA from a heterologous promoter (b).  
(c) Deletion of the single putative transmembrane helix abrogates copper resistance 
to an extent comparable to inactivation of CopA(D442A) (compare to Fig. 12d).  
The strains used for these experiments are wild-type (WT, IU1781), ∆copA 
(IU5975), ∆cupA (IU5971), ∆cupA//Pfcsk-cupA (IU6017), cupA(∆(2-28)-(C)-FLAG 
(IU6086) and cupA(∆(2-28) (IU6084). Experiment was carried out by Ho-Ching 
Tiffany Tsui and Kevin Bruce from Winkler Lab in the Department of Biology.  
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Figure 12: Growth curves of several cupA and copA mutant strains.  
(a) wild-type (IU1781), (b) ∆cupA (IU5971), (c) C-terminally FLAG-tagged cupA, 
cupA-(C)-FLAG (IU6041) (open symbols, dashed line) vs. WT (solid symbols, 
continuous line), (d) C-terminally FLAG-tagged copA, copA-(C)-FLAG (IU6044), 
∆copA (IU5975) and copA (D442A) (IU6054) S. pneumoniae D39 strains in BHI in 
the absence of added copper sulfate (–Cu) or in the presence of 0.2 mM or 0.5 mM 
Cu(II) as indicated. Overnight cultures were diluted to OD620 = 0.002 at the 
beginning of the growth curves for panels (a) to (d). (e) Representative growth 
curves of WT, ∆cupA (IU5971), cupA(C74S) (IU6050), and ∆copA (IU5975) 
strains with the addition of Cu(II) at the indicated time. Strains were diluted from 
overnight cultures to OD620 = 0.002 in BHI at the start of growth curve. CuSO4 was 
added to the cultures at a final concentration with 0.2 mM at OD620 ≈ 0.03 (arrow), 
and the growth of the strains was monitored in the presence of Cu(II).  Cells 
obtained from these growth curves were used for whole cell Western blotting (Fig. 
13) and ICP-MS measurements (Table 4). Experiment was carried out by Ho-
Ching Tiffany Tsui and Kevin Bruce from Winkler Lab in the Department of 
Biology. 
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Figure 13: Western blotting of different cupA and copA strains.  
(a) Quantitative Western blotting using an anti-FLAG antibody and whole cell 
extracts (0.2 mL of ≈0.25 OD620 units) of C-terminally FLAG-tagged sCupA and 
various missense mutants of CupA which show greatly reduced copper tolerance.   
The numbers in parentheses show the signal intensity relative to lane 3 (cupA-(C)-
FLAG strain treated with 0.2 mM Cu).  S, protein standard; lane 1, cupA-(C)-FLAG 
(IU6041), no Cu added; lanes 2-8, cultures collected after the cells were grown in 
BHI containing 0.2 mM Cu for 2.5 h: lane 2, cupA+, no FLAG; lane 3, cupA-(C)-
FLAG (IU6041); lane 4, ∆cupA-(33-aa remnant)-(C)-FLAG) (IU6216); lane 5, cupA 
(∆(2-28)-(C)-FLAG) (IU6086); lane 6, cupA(C74S,3A)-(C)-FLAG (IU6215); lane 7, 
cupA(C74S)-(C)-FLAG (IU6210); lane 8, cupA(3A)-(C)-FLAG (IU6212).  See Fig. 
12e for a representative growth curve for this experiment.  The detected band at ≈30 
kD has a mobility approximately consistent with dimeric CupA-(C)-FLAG but its 
identity is unknown. (b) CopA-(C)-FLAG (≈81 kD) Western blotting of various 
missense copA and cupA strains.  Cells were prepared as described for panel (a). 
Experiment was carried out by Ho-Ching Tiffany Tsui and Kevin Bruce from 
Winkler Lab in the Department of Biology. 
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Figure 14: Both CopA and CupA localize to the cell membrane fraction in S. 
pneumoniae D39.   
The results of a subcellular fractionation of copA-(C)-FLAG (IU6044) (a) and cupA-
(C)-FLAG (IU6041) (b) with visualization by anti-FLAG Western blotting.  
Supernatants (S) or pellets (P) are marked for centrifugation steps, and cell fractions 
are indicated below the blots.  Strains IU6044 and IU6041 were grown exponentially 
in the presence of 0.3 mM CuSO4 to OD620 ≈ 0.2 and fractionated as described60.  
Cultures were centrifuged to obtain secreted and cell-bound fractions, which were 
washed with 1X SMM buffer used for peptidylglycan (PG) digestion (Wash).  The 
resulting pellets were subjected to enzymatic digestion of the PG layer with 
mutanolysin and lysozyme to obtain protoplasts (P of PG digestion) and cell wall (S 
of PG digestion).  Protoplasts were lysed by adding hypotonic buffer (Protoplast), 
with the resulting pellets as cell membrane fraction and supernatants as cytoplasmic 
fraction. Experiment was carried out by Lok-To Sham from Winkler Lab in the 
Department of Biology. 
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2.3.2 Copper binding by sCupA and CopAMBD 
The experiments described above suggest that sCupA and CopAMBD bind Cu(I) directly 
as a means to effect copper resistance.  To test this, I carried out a series of anaerobic 
titration experiments in which CuCl was added to apo-sCupA or apo-CopAMBD in the 
absence and presence of one of two specific Cu(I) chelators, bathocuprione disulfonate 
(BCS) (log2=19.8 for CuI:BCS2) or bicinchoninic acid (BCA) (log2=17.2 for 
CuI:BCA2), thus allowing us to access a range of KCu between 1012 and 1019 M-1.  A 
global analysis of two representative titrations at two protein concentrations is shown 
(Figs. 15-16) with parameter values compiled in Table 1.  These titrations reveal that the 
stoichiometry of Cu(I) binding in both cases to be ≈2 per monomer. sCupA is 
characterized by stepwise affinity constants (KCu1, KCu2 at pH 7.0, 0.2 M NaCl) of 7.4 
x1017 M-1 and 6.2 x 1014 M-1, while the CopAMBD  binds Cu(I) with 2.1 x 1016 M-1 and 2.7 
x 1013 M-1 stepwise affinities (Table 1).  Thus, the putative chaperone sCupA binds Cu(I) 
20- to 30-fold more tightly than the putative Cu acceptor CopAMBD to each of the high 
affinity and low affinity sites. 
2.3.3 Crystallographic structures of sCupA and CopAMBD 
In order to understand the structural basis for the Cu(I) binding stoichiometry, affinity 
and resistance, the x-ray crystallographic structures of sCupA and CopAMBD were solved 
to 1.45 Å and 1.50 Å resolution, respectively (Fig. 17-18; Table 2 for structural 
statistics).   
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Figure 15: Representative binding curves obtained from anaerobic Cu(I) chelator 
competition experiments. 
Experiments were carried out with a mixture of apo sCupA and BCA (or BCS) at 
pH 7.0. Two individual experiments were carried out for BCS or BCA assay. (a) 
BCA competition assay for sCupA.  Open symbols represent A562 values for the 
Cu(I)-(BCA)2 complex. The continuous line represents the results of a global 
analysis of both experiments to a two-step binding, direct competition model.  
Red: 20 μM sCupA and 76 μM BCA. Blue: 30 μM sCupA and 76 μM BCA. (b) 
BCS competition assay for sCupA.  Open symbols represent A483 values for the 
Cu(I)-(BCS)2 complex.  The continuous line represents the results of a global 
analysis of both experiments to the same model. Red: 20 μM sCupA and 86 μM 
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Figure 16: Representative binding curves obtained from anaerobic Cu(I)-chelator 
competition assays. 
The experiments were carried out with a mixture of apo CopAMBD and BCA (or BCS) 
at pH 7.0. Two individual experiments were carried out for BCS or BCA assay. (a) 
BCA competition assay for CopAMBD.  Open symbols, A562 for the Cu(I)-(BCA)2 
complex.  The continuous line represents a global fitting of both experiments to a 
two-step, competition binding model. Red: 16 μM CopAMBD and 90 μM BCA; Blue: 
24 μM CopAMBD and 70 μM BCA. (b) BCS competition assay for CopAMBD.  Open 
symbols represent A483 values for the Cu(I)-(BCS)2 complex. The continuous line 
represents the results of a global analysis of both experiments to a single-site binding, 
direct competition model.  Red: 20 μM CopAMBD, 52 μM BCS; Blue: 30 μM 
MBD i di li d i
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Figure 17: Structure representations of Cu(I)2-sCupA.  
Close-up views of the Cu(I) coordination geometries of protein are shown (b) as are 
solvent-accessible surface areas (colored based on solvent accessibility) (c) around 
the binuclear Cu(I) chelate. Structure statistics compiled in Table 2.  
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Figure 18: Structure representations of Cu(I)2-CopAMBD. 
Close-up views of the Cu(I) coordination geometries of  protein are shown (b) as are 
solvent-accessible surface areas (colored based on solvent accessibility) (c) around 
the binuclear Cu(I) chelate. Structure statistics compiled in Table 2. 
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Each structure reveals an eight-stranded -barrel harboring a binuclear Cu(I) 
cluster with a single Cys from the 2-3 loop (Cys49 in CopAMBD and Cys74 in sCupA) 
functioning as a bridging ligand to each Cu site, denoted S1 and S2.  The S1 site is 
digonal bis-thiolato while the more solvent-exposed S2 site is best described as distorted 
trigonal planar coordination by the three protein-derived ligands, with a long axial 
coordination bond to a Cl– anion from solution (or distorted trigonal pyramidal) (Fig. 20 
and Table 3).  A conserved Cys-gly-Met-asp/asn-Met motif position in the 7-8 loop 
in each protein provides three of the four donor atoms to the Cu(I) ions.  The Cu-Cu 
distance is 3.15 Å in each case.  Both sCupA and CopAMBD adopt a well-known 
cupredoxin fold, with Dali z-scores ranging from 10-12 for cupredoxins of known 
structure, including plastocyanin, nitrosocyanin, nitrous oxide reductase, the CueO 
multicopper oxidase and the CuA site of bacterial cytochrome ba3-type cytochrome c 
oxidase (Fig. 21). 115  However, the metal-ligand disposition is completely novel, 
evidence that nature has adapted this ancient fold to perform Cu(I) trafficking rather than 
electron transfer. 
 Despite adopting identical folds with identical Cu(I) coordination chemistries, 
sCupA and CopAMBD possess contrasting electrostatic surface potentials around the Cu(I) 
binding sites, with the sCupA largely negatively charged and the CopAMBD largely 
positively charged in the vicinity of the Cu(I)-binding sites (Fig. 19).  Electrostatic 
complementarity is an established feature of copper chaperone-MBD pairs, which would 
allow the Cu(I) chelates of each protein to transiently dock and undergo ligand exchange 
and Cu transfer, without dissociation of bound Cu(I) into solvent116.  These disparate 
surface potentials may also explain the weaker overall Cu(I) binding affinity for 
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CopAMBD vs. sCupA (Table 1).  In CopAMBD, Lys22, Lys89 and Lys92 are in close 
proximity of the Cu site and may electrostatically repel the positively charged Cu(I) 
cation; in contrast, Glu52 in sCupA is in a position to electrostatically attract the Cu(I) 
cation. 
 
 
 
Figure 19: Electrostatic surface potential of (a) sCupA and (b) CopAMBD. 
The potential was generated from Cu2 form crystal structure of each protein. The 
binuclear Cu(I) cluster is highlighted using a red box showing the charge 
complementarity between this pair proteins.  
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Figure 20: Cu(I) sites of sCupA and CopAMBD.  
Close-up of the Cu(I) coordination complex in sCupA, with dihedral angles shown.  
(a) Cu(I) site residues of sCupA (C74, C111, M113, M115) with 2mFo - DFc map 
contoured at 2 σ. (b) Cu(I) site residues of CopAMBD (C49, C86, M88, M90) with 
2mFo - DFc map contoured at 2 σ.  (c) The S1 Cu(I) ion is digonal and is very close 
(157º) to a linear coordination complex (180º), while the S2 Cu(I) ion is best described 
as distorted trigonal planar (expected 120º dihedral angles) with an axial coordination 
bond to a Cl– anion from solution, i.e., distorted trigonal pyramidal.  See Table 3 for 
metal-ligand bond distances and angles.   
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Figure 21: Global superposition of CopAMBD with cupredoxin-fold containing 
protein.  
CopAMBD (cyan; Cu ions, red, Cl–, green) with the soluble CuA domain from T. 
thermophilus ba3-type cytochrome c oxidase (PDB code 1cua) (green; Cu ions, 
brown)115.  Cytba3 harbors a CuA binding motif of His…Cys-x3-Cys-x3-His-x2-Met 
(coordinating residues are shown), with the His derived from the 3-4 loop and the 
remaining residues derived form the 7-8 loop which is analogous to the 
Cys….Cys-x-Met-x-Met sequence in sCupA and CopAMBD.  One Cu ion, the S1 Cu in 
CopAMBD is identically positioned with one of the Cu ions of Cytba3; however, the 
cytochrome lacks the more solvent-exposed S2 Cu site.  The DALI156z-score is 10.9, 
with 1.8 Å heavy atom RMSD. 
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2.3.4 Identification of the high and low affinity Cu(I) sites in sCupA and CopAMBD 
The copper trafficking hypothesis117 states the copper transfer moves from donor 
chaperone to target protein with or against a relatively shallow thermodynamic gradient 
as defined by KCu measured with purified proteins27,118.  For sCupA and the CopAMBD, the 
situation is complicated by the presence of two bound Cu(I) ions in each case, with no 
insight as to which site defines the high and low affinity Cu(I) sites in each case.  
therefore NMR spectroscopy was employed to define the sequence of Cu(I) binding, 
exploiting the fact that the stepwise Cu(I) affinities differ by about ≈1000-fold for both 
sCupA and CopAMBD (Table 1).   
Cu(I) binding to the apoproteins was examined by monitoring perturbations in the 
amide chemical shifts of uniformly 15N,13C-labeled samples of sCupA and CopAMBD 
upon sequential filling each of the two Cu(I) sites (Fig. 22).  In each case, the 3-4 and 
7-8 metal binding loops in the apoproteins are conformationally exchange broadened 
indicative of substantial µs-ms dynamics in this region (Fig. 24), as recently established 
for other apo-cupredoxins involved in electron transfer119.  Stepwise addition of Cu(I) 
quenches this line broadening with the addition of the first Cu(I) inducing measurable 
perturbations beyond these loops and into nearby -strands, e.g., the 7 strand; addition 
of the second Cu(I) gives rise to significant perturbations in the metal binding loops only 
(Fig. 24).  These perturbation maps are fully consistent with C49 (CopAMBD) and C74 
(sCupA) functioning as a bridging ligand since filling of both S1 and S2 sites in each 
induces backbone perturbations in both 3-4 and 7-8 loops.   
 
 
56 
 
  
Figure 22: The Met-rich S2 site is the low-affinity site on both CopAMBD and sCupA 
and Cu(I) is transferred only from the S2 site of sCupA to the S1 site of apo-MBD.   
Overlay of the Met thioether methyl (13C-1H) region of an 1H,13C-HSQC spectrum 
for CopAMBD (a) and sCupA (b) acquired in the apo-state (red crosspeaks), Cu1 state 
(green crosspeaks; italics type) and Cu2 states (blue crosspeaks; bold-face type).  
Cyan crosspeaks result when apo-MBD is mixed with 2.0 mol equiv of Cu2 sCupA 
(panel a) or 1.0 mol equiv of Cu2 sCupA (panel b).   
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Figure 23: Cu(I) transfer observed from chemical shift of backbone resonances.  
The Met-rich S2 site is the low-affinity site on both CopAMBD and sCupA and Cu(I) 
is transferred only from the S2 site of sCupA to the S1 site of apo-CopAMBD. 
Overlay of the backbone 1H,15N-HSQC spectra of  CopAMBD (a) and sCupA (b), 
with the same crosspeak color pattern as in panels c-d.  The superposition of cyan 
and green crosspeaks (panels c-f) reveals that incubation of Cu(I)-saturated sCupA 
with apo-MBD results in movement of S2 on sCupA to the S1 site of CopAMBD.  
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  Although the Cu1 and Cu2 states of both sCupA and CopAMBD are readily 
distinguished from one another (Appendix III, Fig. 1-6) they cannot be used to assign 
the high- and low-affinity sites.  The methionine 13CH groups of both sCupA and 
CopAMBD were assigned by 13C-edited NOESY spectroscopy. Direct Met-Cu(I) 
coordination expected to induce a strong downfield shift of the 13Cchemical shift as 
revealed by a 1H,13C-HSQC spectrum (Fig. 22)120.  Only upon addition of the second 
mol•equiv Cu(I) is there a strong downfield shift of  the 13C-1H methyl crosspeaks of 
M88 and M90 of CopAMBD indicative of direct ligation (Fig. 22a).  For sCupA, addition 
of the first mol•equiv of Cu(I) results in a slight upfield shift of the M116 13CH with 
few other changes in the spectrum; only upon addition of the second mol•equiv of Cu(I) 
is there a strong downfield shift of the methyl resonances of M113 and M115.  Inspection 
of the sCupA structure reveals that M116 is quite close to the S1 site ion, and thus reports 
on filling the digonal bis-thiolato S1 site (Fig. 22b).  I conclude that the high affinity 
Cu(I) site on both CopAMBD and sCupA is the bis-thiolato S1 site, with the more solvent-
exposed Met-rich S2 site the low affinity Cu(I) site in each case.  
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Figure 24: NMR chemical shift perturbation analysis of sCupA and CopAMBD 
induced by Cu(I) binding.   
Ribbon representation of the changes in backbone amide chemical shift upon Cu(I) 
binding by sCupA (a, b) and CopAMBD (c, d).  Panels a and c represent ∆ppm (Cu1–
apo) while panels b and d represent ∆ppm (Cu2–Cu1).  The ribbon is painted white for 
Pro residues and black for those resonances broadened beyond detection in the apo-
state in each case.    
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2.3.5 Cu(I) is transferred from the S2 site on sCupA to the S1 site on CopAMBD 
Next whether Cu(I) bound to the putative donor sCupA could be transferred to acceptor 
CopAMBD was examined, by taking advantage of the distinct spectroscopic signatures of 
Cu(I) bound to each of the two Cu(I) sites (Fig. 22a-b).  This experiment was performed 
using an NMR-based strategy98 by mixing 13C,15N-sCupA with unlabeled CopAMBD or 
unlabeled sCupA with 13C,15N-CopAMBD, with sCupA loaded with two mol•equiv of 
Cu(I) as copper donor.  When unlabeled apo-CopAMBD is mixed with stoichiometeric Cu2 
13C,15N-sCupA, one Cu(I) is lost, specifically from the low-affinity Met-rich S2 site as 
evidenced by a return of the 13C-1H crosspeaks of M113 and M115 to their positions in 
Cu1 sCupA (Fig. 22b); the same is evident on inspection of the 1H,15N-HSQC spectrum 
of sCupA, with the blue (Cu2) resonances lost, and concomitant superposition of the 
green (bona fide Cu1 sCupA) and cyan (Cu2 sCupA mixed with apo-CopAMBD) 
crosspeaks (Fig. 23b).  There is no trace of apo-sCupA in these spectra.  Monitoring the 
same reaction with excess  (2:1) unlabeled Cu-saturated sCupA and 13C,15N-apo-
CopAMBD reveals formation of only the bona fide Cu1 CopAMBD with the S1 sites filled 
(Fig. 22a), with no evidence of the Cu2 or apo-MBD in these mixtures (Fig. 23a).  Thus, 
even in the presence of excess Cu bound to sCupA, only the high affinity S1 site on the 
CopAMBD is capable of accepting the Cu(I) from sCupA, and that Cu(I) is donated from 
the more solvent-exposed lower affinity S2 site on sCupA. 
 The reverse experiment was also done in which stoichiometric 13C,15N-labeled 
Cu1 CopAMBD was mixed with unlabeled apo-sCupA.  There is no change in the spectrum 
(Fig. 25), thus revealing that despite the higher affinity, the S1 site on sCupA is unable to 
strip the MDB of its bound Cu(I).  Only when excess apo-sCupA is added or Cu(I) is 
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available from the low affinity S2 site does any Cu(I) move to sCupA. Thus, efficient 
Cu(I) transfer is preferentially unidirectional, but likely depends on the molar ratio of 
CupA and CopA in the membrane. 
2.3.6 Cu(I) coordination by CupA but not by CopAMBD is essential for copper 
resistance of S. pneumoniae 
In order to further understand the essentiality of cupA for mediating copper resistance we 
characterized allelic replacement strains using our structures as a guide (Fig. 17-18) in 
which the cupA gene was replaced with a mutant cupA allele wherein all Cu-coordinating 
7-8 loop residues (C111, M113 and M115) were substituted with Ala (cupA(3A)), 
and/or the bridging ligand C74 was replaced with Ser (cupA(C74S); cupA(C74S,3A)).  
Biochemical experiments reveal that C74S sCupA binds a single mol•equiv of Cu(I) with 
a low affinity as measured by a BCA competition assay (KCu≈1012 M-1) but adopts a fold 
identical to that of wild-type sCupA with only local structural perturbations around the 
site of the substitution (Fig. 26).  In the absence of added copper, all metal-liganding 
mutant strains grow similarly to that of the cupA-(C)-FLAG strain (Fig. 27a).  However, 
in the presence of 0.2 mM Cu(II), growth of the cupA(3A) strain is significantly inhibited 
while the cupA(C74S) and cupA(C74S,3A) both fail to grow significantly (Fig. 27b), 
despite the fact that all CupAs accumulate to level greater than that of wild-type CupA 
(Fig. 13a).  At 0.5 mM Cu(II), under conditions where the wild-type strain is somewhat 
affected, neither strain is able to grow (Fig. 28).  In fact, the behavior of cupA(C74S) 
strain is indistinguishable from a copA(D442A) strain expressing a catalytically inactive 
CopA (Fig. 27c).  Interestingly, Western blotting reveals that C-terminally FLAG-tagged 
CopA accumulates to very high levels in both strains, as well as in the ∆cupA strain  
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Figure 25: Apo-sCupA is unable to chelate Cu(I) from Cu0.8 CopAMBD when mixed at 
a molar ratio of 1:1.   
Overlay of a selected region of an 1H,15N-HSQC spectrum of CopAMBD acquired in 
the apo-state (red crosspeaks), following addition of 0.8 Cu(I) (green crosspeaks; 
italics type) and 1.8 Cu(I) (blue crosspeaks; bold-face type) and after mixing Cu0.8 
CopAMBD with unlabeled apo-sCupA (cyan crosspeaks).  The superposition of cyan 
and green crosspeaks reveals that apo sCupA is unable to strip the Cu(I) from S1 Cu-
ligated CopAMBD, despite its higher affinity at equilibrium.  Incubation of 
stoichiometric Cu1.8 CopAMBD with apo-sCupA results in the low affinity S2 Cu 
moving to the high affinity S1 Cu site on sCupA, which is thermodynamically 
favorable.  The S1 Cu on CopAMBD does not transfer under these conditions. 
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(Fig. 13b).  Analysis of the total cell-associated metal content of these strains by ICP-MS 
reveals a substantial increase in total cellular Cu, which reaches a level ≈5-fold higher 
than WT cells 3 h after addition of 0.2 mM Cu in the ∆cupA and cupA(C74S) strains 
(Table 4). In contrast, when a substitution that is analogous to C74S in CupA is 
introduced into the CopAMBD in the copA gene (copA(C49S)), copper resistance is 
unaffected at both 0.2 mM (Fig. 27c) and 0.5 mM Cu(II) (Fig. 28c).  Consistent with this, 
FLAG-tagged C49S CopA accumulates to a level similar to that of wild-type CopA 
rather than to that of Cu-sensitive mutants (Fig. 13b).  Thus, these experiments establish 
that the major function of the CupA in copper stress resistance in Spn is not to chaperone 
Cu(I) to the CopAMBD but is instead required for direct copper delivery to the 
transmembrane Cu(I) binding sites in CopA for efflux and/or to sequester Cu(I) during 
copper stress in an effort to mitigate the effects of cellular Cu toxicity (Table 4).  
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Figure 26: Structural characterization of integrity of C74S sCupA.  
(a) Superposition of the  1H,15N-HSQC spectra of apo-C74S sCupA (cyan 
crosspeaks) and the wild-type apo-sCupA (red crosspeaks).  Spectral perturbations 
are structurally near the site of the substitution localized to the 3-4 and 7-8 
loops, revealing that C74S adopts a wild-type like fold.  (b) BCA competition 
experiment.  Titration of Cu(I) into 80 µM BCA alone (cyan) or in the presence of 
76 µM BCA and 20 µM apo-C74S sCupA (red) or 74 µM BCA and 30 µM apo-
C74S sCupA (blue).  The continuous lines through the data represent the results of a 
global analysis of all experiments to a single site, direct competition model with 
KCu= 3.6 (±0.6) x 1012 M-1, or ≈200-fold weaker than the low-affinity Met-rich S2 
Cu site of sCupA.
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Figure 27: Mutagenesis of CupA Cu(I) binding residues partly or completely 
abrogates Cu(I) resistance by S. pneumoniae, but not in CopAMBD. 
Representative growth curves for the indicated S. pneumoniae strains in BHI in the 
absence (a) or presence (b, c) of 0.2 mM Cu(II) added to the growth medium.  In all 
cases, two independent isolates of the same strain designation were constructed and 
duplicate (or more) growth experiments were carried out with each of the two strains. 
Experiment was carried out by Ho-Ching Tiffany Tsui and Kevin Bruce from Winkler 
Lab in the Department of Biology. 
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Figure 28: Growth rate analysis of cupA and copA mutant strains.   
Mutation of the Cu(I) ligands in the 7-8 loop in CupA (C111A/M113A/M115A; 
designated 3A) gives rise to an intermediate copper sensitivity phenotype, in 
contrast to a M113A/M115A mutant (designated 2A) cupA strain. (a) cupA(3A) 
(IU6015) strain grown in the absence and presence of 0.2 mM or 0.5 mM Cu(II) 
added to the growth media (compare to WT and cupA(C74S) growth curves, 
Supplementary Fig. 4a and Fig. 5b, main text).  (b) Growth curves of wild-type 
(WT) (IU1781), cupA(2A) (IU6585), cupA(3A) (IU6015), cupA(C74S) (IU6050), 
and cupA(C74S,3A) (IU6052) strains in 0.5 mM Cu(II).  (c) The copA(C49S) MBD 
mutant grows like WT, compared to copA(D442A) and ∆copA and cupA mutant 
strains which do not grow under these conditions (panel b).  Growth curves for 
indicated copA mutants are compared to the WT (IU1781) strain in 0.5 mM Cu(II). 
Experiment was carried out by Ho-Ching Tiffany Tsui and Kevin Bruce from 
Winkler Lab in the Department of Biology. 
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2.4 Implication of the work 
In this work, a new structural paradigm for copper trafficking and resistance was 
characterized in the Gram-positive respiratory pathogen S. pneumoniae.  Soluble CupA 
and CopAMBD are isostructural and of opposite electrostatic surface potentials, and each 
harbors a binuclear Cu(I) cluster in the context of a novel architecture not previously 
observed in bacterial copper trafficking.  The Cu(I) binding affinities of sCupA and 
CopAMBD differ significantly from one another, and although sCupA binds Cu(I) more 
tightly overall than CopAMBD, copper transfer is preferentially down a thermodynamic 
gradient from the low affinity S2 site of sCupA to the high affinity S1 site of CopAMBD 
(∆∆G=–2.0 ±0.3 kcal mol-1), as found in other, but not all, Cu(I) chaperone 
systems27,118,121.  CupA therefore satisfies all established criteria for designation as a 
copper chaperone for a copper transporter122, but is the first one known to be inserted into 
the plasma membrane.  Remarkably, deletion of the transmembrane helix reduces copper 
resistance to level equivalent to that of a catalytic site mutant in CopA, thus revealing that 
membrane localization is uniquely essential for copper resistance in S. pneumoniae.  
This is the first instance to our knowledge where biological studies clearly 
establish that deletion or functional inactivation of the copper chaperone reduces copper 
resistance to a level identical to deletion or inactivation of the copper transporter.  This is 
particularly striking when one considers that metallation of metalloproteins is generally 
thought to require a chaperone when bioavailable Cu(I) is limiting; at excess copper 
levels, the classic “chaperone” function can be nominally bypassed116.  The obligatory 
requirement of the CupA chaperone in Cu resistance in Spn was missed in the previous 
report, which suggested that a Spn strain encoding a translationally terminated cupA gene 
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gave rise only to a more modest copper sensitivity phenotype1.  We show here that CupA 
protein levels in all cupA missense strains that express CupA with diminished Cu(I)-
binding affinities accumulate to a level greater than that in a wild-type background; 
furthermore, CopA accumulates to even higher levels relative to a WT strain under 
conditions of Cu stress (Fig. 13).  Selected mutant strains that exhibit greatly diminished 
copper resistance (∆cupA, cupA(C74S) and ∆copA) accumulate far more cell-associated 
Cu (Table 4). A hyperaccumulation of both CupA and CopA in these cells may be 
reporting on hypersensitivity or continued derepression of CopY-mediated transcription 
of the cop operon in a failed effort to resist the effects of increased cytoplasmic copper. 
Two pieces of evidence suggest that the observed ability of sCupA to donate Cu 
to the N-terminal MBD of CopA is not strongly correlated with cellular Cu resistance 
under the growth conditions examined here.  First, the cupA(3A) strain, which encodes a 
CupA which likely lacks Cu(I) binding to the low affinity S2 donor site, gives rise only to 
an intermediate Cu-sensitivity phenotype at 0.2 mM Cu (Fig. 2).  Secondly, inactivation 
of the S1 acceptor site in copA(C49S) is functionally silent (Fig. 27).  Thus, although Cu 
transfer from the S2 site of CupA to the S1 site of CopAMBD occurs spontaneously, we 
suggest that this may occur only under non-stressed or “housekeeping” conditions since it 
is not strongly relevant to the cellular response of Spn to acute Cu toxicity.  Other 
functional roles for CupA are possible, particularly so given that the metallochaperone 
for the CuA subunit of a bacterial cytochrome c oxidase is itself a membrane-anchored 
cupredoxin-fold protein that binds a single Cu(I) ion.96,98 However, CupA is not 
performing this role in S. pneumoniae since this bacterium lacks cytochrome c oxidase 
and an electron transport chain.14  
69 
 
Recent structural studies of the apo metal-free bacterial CopAs67,115 support a 
model in which the N-terminal MBD (not visualized in the crystallographic structure of 
Legionella CopA) plays a regulatory role.  The MBD likely docks against the actuator 
cytoplasmic domain (Fig. 29) and inhibits ATP hydrolysis by the pump in the absence of 
Cu(I); metal binding by the MBD is hypothesized to disrupt this interaction and 
allosterically activate ATP hydrolysis and Cu(I) transport across the membrane.  It has 
been shown that the cytoplasmic copper chaperone Atx1 can deliver Cu(I) to either the 
N-terminal MBD, which is not on-pathway for copper transfer, or the transmembrane site 
directly61, the latter hypothesized to occur via docking to the positively charged platform 
region that surrounds the putative entry site for Cu transfer67.  Thus, the negative 
electrostatic surface potential of sCupA is complementary to both the MBD and the 
platform region of CopA, and may facilitate transient docking and Cu delivery to either 
site (Fig. 29). 
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Figure 29: Cu(I) resistance mechanism proposed based on data in chapter II.  
(a) Homology model predicted by Swiss-Model157,158 of S. pneumoniae CopA shown 
to scale with our structures of sCupA and CopAMBD.  R102 defines the N-terminus of 
the model based on LpCopA structure67, while E99 defines the most C-terminal 
residue visible in our CopAMBD structure.  This places the MBD in close proximity to 
the actuator domain (yellow) where it can influence the rate of hydrolysis of D442 in 
the phosphorylation domain (shaded blue).  Possible paths of copper delivery by 
CupA are represented by the cyan arrows.  (b) The electrostatic surface potential of 
the model of Spn CopA suggest that the positively charged MBD (Fig. 17-18) could 
preferentially dock against the negatively charged actuator domain region, while 
CupA could be electrostatically guided to the positively charged platform helix region 
in order to deliver Cu(I) directly to the entry site just above the transmembrane (TM) 
binding sites (not shown).   
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Table 1: Cu(I) binding affinities for sCupA and CopAMBD * 
Protein log KCu1 (M-1) log KCu2 (M-1) log2,Cu (M-2) 
sCupA 17.9 (±0.3) 14.8 (±0.2)2 32.6 (±0.3) 
CopAMBD 16.3 (±0.1) 13.4 (±0.3) 29.8 (±0.3) 
* These parameters were measured via global analysis of multiple anaerobic CuCl 
titrations using BCA or BCS as a competitor Cu chelator (see Figs. 15-16 for titrations) 
using a nonlinear least squares fit to a stepwise two-Cu(I) binding model in both cases.  
2Reflects the average value from BCA and BCS titrations.  Conditions: 25 mM Hepes, 
0.2 M NaCl, pH 7.0, 22 ºC). 
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Table 2:  Crystallographic data collection and refinement statistics 
 Cu2 sCupA Cu2 CopAMBD 
Data collection   
Space group P21212 P212121 
Cell dimensions　　   
    a, b, c (Å) 47.208, 78.647,23.455 35.455, 37.329, 69.294 
 ()  90, 90, 90 90, 90, 90 
Resolution (Å)a 50.00-1.45 (1.48-1.45) 50.00-1.45 (1.48-1.45) 
Rsym or Rmergea 0.024 (0.183) 0.035 (0.363) 
I / Ia 46.5 (8.2) 43.0 (6.3) 
Completeness (%)a 99.8 (99.5) 99.9 (100.0) 
Redundancya 6.6 (6.1) 11.4 (10.6) 
   
Refinementb,c   
Resolution (Å) 21.00-1.45 20.00-1.50 
No. reflections 16233 15410 
Rwork / Rfree 0.1778/0.1998 0.2134/0.2430 
No. atoms   
Protein 774 783 
Ligand/ion 3 3 
Water 192 122 
B-factors   
Protein 14.73 23.37 
Ligand/ion 12.44 20.59 
Water 26.91 35.05 
R.m.s. deviations   
Bond lengths (Å) 0.017 0.020 
Bond angles () 0.913 0.766 
aValues in parentheses are for highest-resolution shell. 
bStructures have been deposited with Protein Data Bank under accession codes 
4F2E (sCupA) and 4F2F (CopAMBD), respectively.  
cTwo crystals were used to collect diffraction data for CopAMBD. One crystal was 
used to collect diffraction data of sCupA. 
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Table 3: Crystallographically determined copper coordination bond lengths and bond 
angles for Cu2 sCupA and Cu2 CopAMBD a   
Cu site Bond Distance Å Structure Angle ˚ 
sCupA S1 Cu – C74 S 2.16 C74 S – Cu – C111 S 157.31 
 Cu – C111 S 2.18   
     
sCupA S2 Cu – C74 S 2.25 C74 S – Cu – M115 S 118.26 
 Cu – M113 S 2.31 C74 S– Cu –M113 S 128.66 
 Cu – M115 S 2.32 M113 S – Cu – M115 S 108.54 
 Cu – Cl- 2.33 C74 S – Cu – Cl– 100.06 
   M113 S – Cu – Cl– 93.21 
   M115 S  – Cu – Cl– 97.67 
     
CopAMBD S1 Cu – C49 S 2.16 C49 S – Cu – C86 S 158.52 
 Cu – C86 S 2.15   
     
CopAMBD S2 Cu – C49 S 2.23 C49 S – Cu – M90 S 118.52 
 Cu – M88 S 2.30 C49 S– Cu –M88 S 121.02 
 Cu – M90 S 2.24 M88 S – Cu – M90 S 114.64 
 Cu – Cl- 2.47 C49 S – Cu – Cl– 99.91 
   M88 S – Cu – Cl– 90.92 
   M90 S  – Cu – Cl– 103.32 
aSee Table 2 for crystallographic data collection and refinement statistics on which these 
data are based. 
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Table 4: Total cell-associated copper content (in ng/mg protein) of various Spn strains in 
the absence and presence of 0.2 mM added to the growth mediuma 
Strain No Cu addedb 0.2 mM Cu, 2 hb 0.2 mM Cu, 3 hc 
WT (IU1781) 193 (±50) 285 (±32) 176 (±3) 
∆cupA (IU5971) 223 (±29) 906 (±402)d 889 (±168)d 
cupA(C74S) (IU6050) 187 (±30)c 631 (±103)d 928 (±540) 
∆copA (IU5975) 162 (±16) 624 (±88)d 809 (±14)d 
aCells used for this experiment were obtained from 2 to 3 (n) experiments, derived from a 
representative growth curve like that shown in Fig. 12e for the Cu-containing samples.  
OD620 ranged from 0.1-0.3.  bFrom n=3 biological replicates.  Student’s t-test shows that 
the differences in Cu content observed among the No Cu added samples are not 
significant.  cFrom n=2 biological replicates. dDifference in Cu content between the WT 
strain vs. other strains for samples collected at 2 and 3 h post Cu addition is statistically 
significant (p≤0.05). Measurement was carried out by John P. Lisher from Giedroc lab.  
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CHAPTER III: Solution structure of apo-sCupA and the functional role of each 
Cu(I) binding site in CupA 
3.1 Introduction 
The physiological function of cytoplasmic copper chaperones has received 
considerable attention over the last several years.  The early copper trafficking hypothesis 
proposed that the chaperone was responsible for delivering Cu(I) to its cellular target 
without dissociation into solvent, mitigating copper-mediated cellular damage.123  
However, in eukaryotic cells, there is no observable copper hypersensitivity for any of 
the mutants lacking copper chaperones in each of three major pathways: (1) to the trans-
Golgi network; (2) to superoxide dismutase; and (3) to cytochrome c oxidase.  In 
prokaryotes, CopZ-like copper chaperones were proposed to transfer Cu(I) either to the 
copper-responsive metallosensor leading to transcriptional derepression of the Cu 
resistance cop operon, and/or to the copper exporting ATPase that pumps Cu(I) out of the 
cytoplasm.59,61 However, genomic deletion of copZ in Listeria monocytogenes, for 
example, was shown to have little effect on the transcription of the cop operon or on 
growth rate under copper stress92, suggesting that the CopZ-like chaperone may not be 
playing an obligatory role in either proposed trafficking function.  A subsequent model 
derived from studies of the cyanobacteria copper chaperone scAtx1 proposed that scAtx1 
is not an obligatory player for copper delivery to cellular targets either; rather, scAtx1 
alongside glutathione, buffers Cu(I) to very low “free” levels, by preventing Cu(I) from 
gaining access to other non-cognate metal sites, thereby preventing Cu(I) toxicity.116  
Since Cu(I) binding by CupA was shown to be essential for Cu(I) resistance, how 
CupA functions in this process as well as the functional role played by each of the two 
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Cu(I) sites is not yet established.  Further, a high resolution structure of apo-sCupA is not 
yet available.  The essentiality of CupA in pneumococcal Cu(I) resistance thus provides 
an excellent system with which to discriminate between the two competing models of 
copper chaperone function: (1) the copper chaperone is on-route for cytoplasmic Cu(I) 
efflux, or (2) the copper chaperone is exclusively involved in buffering free Cu(I) to very 
low levels.  
In this chapter, biophysical, biochemical and molecular microbiological 
approaches are employed to determine the solution structure of apo-sCupA and evaluate 
the functionality of each Cu(I) site in CupA in vivo.  Our findings reveal the apo-sCupA 
adopts the same cupredoxin fold as Cu2-CupA with a dynamic Cu(I) binding loop 
demonstrated by both backbone and side chain measurements.  The side chains of 
coordinating residues in the S1 Cu site are pre-organized for Cu(I) binding while the S2-
specific side chains (M113, M115) are highly dynamic.  The high affinity S1 Cu(I) site is 
dispensable for cellular Cu(I) resistance, while the low affinity S2 Cu(I) binding site is 
essential for bacterial growth under copper stress.  These growth phenotypes track with 
total cell associated Cu(I), consistent with the hypothesis that the S2 site in CupA 
delivers Cu(I) directly to the to CopA for export.  A triple substitution of the proposed 
metal entry site (MBS) in CopA in abrogates Cu resistance, and a CopZ tethered to the 
plasma membrane via a cupA TM helix also fails to protect pneumococcus from Cu 
poisoning.  These studies are consistent with a direct physical interaction of the CupA S2 
Cu with the MBS of CopA that is on pathway for Cu(I) efflux.   
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3.2 Methods 
3.2.1 Measurement of apo-sCupA backbone dynamics 
15N relaxation experiments were acquired using two-dimensional, proton-detected 
heteronuclear NMR experiments.124  R1 values were measured from the spectra recorded 
with ten different duration of delay T: T = 10, 50, 110, 190, 310, 500, 650, 1000, 1500 
and 1900 ms. R2 values were determined from the spectra recorded with ten different 
durations of the delay T: T = 10, 30, 50, 90, 110, 150, 190, 210, 230 and 250 ms.  1H-15N 
heteronuclear NOE values were determined from spectra recorded in the absence and 
presence of a 3 s 1H pre-saturation period.  The rotational correlation time ( ) of apo 
sCupA was estimated from the data analysis according to model-free formalism using 
Tensor V2.0125.  
3.2.2 Measurement of apo-sCupA side chain dynamics 
To measure the intra-methyl 1H-1H dipole-dipole cross-correlated relaxation rate 
()126,127, a set of pairs of experiments were recorded.  The signal intensity (Ia) in the first 
experiment during a variable relaxation delay (T) depends on spin-dynamics in the I = 3/2 
manifold of the Met  methyl 1H spin-system.  The signal intensity (Ib) in the second 
experiment is determined by spin-dynamics in the I = 3/2 and I = 1/2 manifolds.  The 
cross-correlated rate () is related to the intensity ratio (Ia/Ib) in the given equation at 
each time T:  
(1) 
Ten values of T = 2, 5, 8, 12, 17, 22, 27, 32, 37, 42 ms were used for both experiments.  
An  value was obtained by fitting the experimentally determined Ia/Ib ratio as a function 
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of T to eq (1) (see Fig. 35 for representative fits).  The axial order parameters ( ) 
were then calculated from eq (2) using the rotational correlation time ( ) of apo sCupA 
(determined above): 
(2) 
where = 1.813 Å, = 90°. 
 
3.2.3 Apo-sCupA structure calculation  
Distance restraints were derived from 3D 15N-edited NOESY-HSQC (m = 200 
ms) and 13C-edited NOESY-HSQC (m = 150 ms) experiments. Backbone dihedral angle 
restraints for three-dimensional structure calculation were generated from apo sCupA 
backbone assignments using TALOS+.128  Initial NOE cross-peak assignments were 
obtained using automatic NOE assignment and structure calculation algorithm 
implemented in CYANA 2.1.129,130  Partial assigned peak lists were then further manually 
assigned and confirmed during subsequent CYANA calculations.  In total, 100 structures 
were calculated using CYANA and subsequently refined using a simulated annealing 
protocol with Xplor-NIH.131  After iterative refinement and editing of the distance 
restraints based on the NOESY spectra to remove incorrect and ambiguous assignments, 
a final ensemble of 18 structures with the lowest energies were chosen for analysis and 
were deposited in the Protein Data Bank (entry 2MRY).  Substantially complete 
resonance assignments for apo-sCupA have been deposited in the BMRB under accession 
number 25098. 
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3.2.4 In vitro redox potential measurement 
The assay is modified based on study of Atox1 in yeast.2 Apo sCupA and 
CopAMBD were prepared as previously described132 in the anaerobic glove box. A typical 
concentration of 30 M proteins was used to perform the measurement to be incubated 
with a mixture of GSH and GSSG present at different ratios in 50 mM potassium 
phosphate, pH 7.0. Concentrations of [GSH] and [GSSG] were chosen so that: 
mMGSSGGSH 10][2][  . Incubation time was 2 hours. The reaction was quenched 
by adding 10 % (w/v) TCA. Followed by centrifugation at 10K for 30 min, the pellet was 
washed with ice-cold acetone twice and resuspended in Laemmli sample buffer 
containing 4 M urea. The protein was labeled with 5 mM EZ-link maleimide-PEG11-
miotin at room temperature for 3 hours. The labeling was quenched by adding excessive 
amount of cysteine. The labeled protein was subject to 18 % SDS-PAGE to determine 
reduced vs. oxidized protein. Incorporation of EZ-Link maleimide-PEG11-biotin, 
indicating the presence of reduce cysteine, was identified by a mobility shift of labeled 
protein. Protein quantification in bands was done by densitometry using ImageJ. The 
ratio of reduced Cys residues to total was plotted against the redox potential of the 
GSH/GSSG pair and fit to the following Nernst equation: 
)
1
ln(
20 f
f
F
RTEE   
f is fraction of reduced Cys residues. E is the redox potential of the GSH/GSSH pair in 
the solution and E0 is the standard redox potential of the Cys pair in the protein. The 
fitting was done in Kaleidagraph. Redox potential of GSH/GSSG pair was calculated 
using the following equeation: 
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RTEE GSH   
EGSH is the standard redox potential of GSH/GSSG pair, which is -0.24 V. 2 
3.2.5 CupA oxidation by Cu(II)  
Unlabeled apo sCupA was prepared in the anaerobic glove box in 25 mM Tris, 
pH 7.0 and 200 mM NaCl. A typical 5 or 10 M concentration of protein was used in the 
assay. Protein was mixed with excessive amount of BCS (> 10 fold) followed by titration 
of CuCl2 into the solution. Cu(II) reduction by sCupA was quantified by monitoring the 
absorption of BCS2:Cu(I) complex at 483 nm. The reduced Cys residue in sCupA after 
titration was quantified by DTNB assay.  
 For NMR sample, 13C, 15N labeled sCupA was prepared in the anaerobic glove 
box in 25 mM Tris, pH 7.0 and 200 mM NaCl. A typical 400 M concentration of 
protein was used and CuCl2 was added to a final concentration of 800 M to fully oxidize 
sCupA.  
3.2.6 In situ thiol-labeling experiment  
Strains subject to thiol-labeling were inoculated in 3 mL BHI and allowed to grow 
overnight at 37 °C and 5 % CO2. Then cells were to diluted to OD 0.004 in 30 ml BHI 
from O/N cultures. The cells were allowed to grow till OD 0.25 for harvesting. If the 
effect of oxidative stress on CupA was assessed, various oxidants were added to each cell 
culture 30 min before harvesting. The cell pellet was washed twice using PBS buffer with 
1 mM BCS to remove extracellular copper. The washed pellet was resuspended in the 
lysis buffer (100 mM Tris, pH 8.0, 1 mM CaCl2, 3 mM EDTA, 18 % (w/v) sucrose, 1 
mM BCS). The supernatant from cell lysate was treated with 20 mM AMS (100 mM 
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stock) to label reduced Cys residues. Reduced or  oxidized CupA protein control was 
prepared by incubating supernant from cell lysate with 5 mM TCEP or 0.4 mM 4-DPS 
respectively. The labeled samples were subjected to 18 % SDS-PAGE. Incorporation of 
AMS to reduced Cys residues was shown as a shift in the gel band.  
3.3 Results 
3.3.1 Resonance Assignments and Solution Structure of apo CupA  
Uniformly 13C, 15N labeled apo-sCupA (residues 26-123) was subjected to 
multidimensional NMR spectroscopy using standard methods to obtain ≈91.6% of all 
possible proton assignments in the ordered regions and 87.9% overall.  Four residues, 
residues 113-116, were characterized by missing resonances in the 1H, 15N-heteronuclear 
single quantum coherence (HSQC) spectrum of apo-sCupA and include two Met 
residues, M113 and M115, that coordinate the S2 Cu(I) ion found in the loop containing 
three of the four Cu(I) binding residues, between the 7 and  (Fig. 30). The three-
dimensional structure of apo-sCupA is well defined by the NMR data with 2201 NOE-
based distance constraints, including 1067 long-range constraints, and 130 dihedral angle 
constraints (Table 5).  The final bundle of 18 structures is characterizes by a pair-wise 
atomic rmsd values of 0.1 Å and 0.6 Å for the backbone and all heavy atoms, 
respectively (Fig. 31).  Apo-sCupA in solution adopts the same cupredoxin-like fold as 
Cu2-sCupA132 where nearly all regions of the molecule are well defined, with the 
exception of the N-terminal region and the 7- loop, from residues 112-116 (Fig. 32).  
The ordered regions of apo-sCupA superimpose extremely well on the structure of Cu2-
CupA (Fig. 33a), fully consistent with previous chemical shift perturbation 
experiments.132 The lack of constraints for the Cu(I) binding loop largely parallels the 
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missing of the cross-peaks in the 1H, 15N HSQC spectrum, indicating flexibility in the 
backbone of this region of the loop on the µs-ms timescale.  In contrast, both the 
positions of the backbone and the side chain donor atoms of the high-affinity S1 Cu(I) 
ion, C74 in the 3- loop and C111 in the 7- loop, appear pre-organized for Cu(I) 
binding (Fig. 33b). 
 
 
 
 
Figure 30:  Close-up of the binuclear Cu(I) cluster in Cu2-bound sCupA.  
All the Cu(I) binding ligands reside on the two loops between 3-4 and 7-8. The 
loop between b7-b8 is disordered in the apo-sCupA solution structure (residue 112-
116).  
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Figure 31: Solution structure ensemble of apo-sCupA.  
All atom representation of the ensemble of the 18 lowest-energy models. Note the 
side chains of residues in the loop between 7-8 are not converging due to 
dynamics.  
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Figure 32: Cartoon representation of apo-sCupA solution structure. 
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Figure 33: Structural overlay of apo and Cu(I)2 form sCupA 
(a) Cartoon representation of the ensemble of apo-sCupA overlay with Cu2-sCupA. 
The overall fold is identical between apo and Cu2 form. (b) Close-up of the side 
chains of C74 and C111 in apo-sCupA structure. The pre-organized side chains 
may facilitate in the high-affinity Cu(I) binding. 
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3.3.2 Dynamics of the Cu(I) Binding 7- Loop.   
The four residues with missing cross-peaks in the 1H,15N-HSQC spectrum 
(residues 113-116) are likely due to intermediate chemical exchange broadening between 
two or more distinct conformations. Fast timescale (ps–ns) internal dynamical 
fluctuations can be approximated by the magnitude of 1H-15N hNOE124, where a 
hNOE≥0.8 is considered rigid, and correspondingly smaller values increasingly dynamic 
on this fast timescale.  This experiment provides insights to changes in backbone 
flexibility upon sequential Cu(I) loading of the high affinity S1 and low affinity S2 Cu(I) 
sites (Fig. 34).  Inspection of these data reveals that Cu(I) binding to S1 site completely 
quenches backbone disorder in the C111 in the 7- loop, while loading of the second 
Cu(I) into the S2 site has little or no effect on the hNOE values, and thus backbone 
flexibility.  
 Methyl groups are excellent reporters of side chain disorder on the ps-ns and µs-
ms timescale.126 Given the relatively high abundance and reasonably good distribution of 
methionine residues (7 total) in sCupA, particularly in the Cu(I) binding loop (M113, 
M115), we used the Met CH3 groups to compare the flexibility of the Cu(I) binding loop 
with the core of the protein. 
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Figure 34: Plot of backbone 1H-15N heteronuclear NOE. 
Coloring: apo (red), Cu1 (blue) and Cu2 (green) states of sCupA vs. residue number. 
Regions of significant difference among three states are colored with yellow box. 
Secondary structures based on apo-sCupA solution structure and Cu2-sCupA 
crystal structures are depicted on the top.  
88 
 
Intra-methyl 1H-1H dipole-dipole cross-correlated relaxation rates () of the Met 
CH3 (Fig. 35-36) reports on the local dynamics on the ps-ns timescale from which one 
can calculate the axial order parameters of each side chain CH3 group (S2axis).  For side 
chain methyls that are highly dynamic at the ps-ns timescale, the S2axis value is close to 0, 
while for residues that are ordered the value is close to 1.  The S2axis values of the Met 
CH3 groups were measured in all three states: apo, Cu1 (S1-bound), and Cu2 states and 
compared with one another (Fig. 36).126,127 M91, whose side chain is stabilized by 
interaction with neighboring residues in both the apo- and Cu2-states, shows consistently 
larger S2axis values of ≈0.4 while M28, near the N-terminus, has S2axis values less than 
0.05 for all three states.  M46, solvent exposed and just C-terminal to the 1 strand 
generally gives low S2axis value as well.  The two S2 ligands, M113 and M115, as well as  
M116 and M120 exhibit similar mobilities in the apo-state, with S2axis≈0.15, with the 
binding of the S1 and S2 Cu(I) ions inducing opposite effects.  Filling of the S1 Cu(I) site 
detectably quenches motional disorder in M116 and M120, while significantly enhancing 
disorder in the two S2-Cu ligands, M113 and M115.  While this disorder in M113 and 
M115 methyls is quenched in the Cu2 state as a result of formation of Cu-S coordination 
bonds, rising to an S2axis comparable to that of M91, M116 positioned closest to the S1 
Cu, and M120 are characterized by increased mobility in the fully Cu-loaded state.  The 
origin of these latter effects is unknown, particularly since M120 is buried in the core in 
both the apo- and Cu2 states, although inspection of the NMR ensemble of apo-sCupA 
(Fig. 31) reveals that rotation about the C-S bond is clearly possible. 
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Figure 35: Build-up curves as a function of intensity ratio (Ia/Ib) used to determine 
the intra-methyl 1H-1H dipole-dipole cross-correlated relaxation rate (). 
For each of the seven Met CH3 groups in sCupA in each of three ligation states, 
apo (red), Cu(I) bound to the S1 sites (blue), and both S1 and S2 sites filled 
(green) are shown. related to the axial order parameter, S2axis and the molecular 
rotational correlation time, c. 
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Figure 36: Plot of order parameters of each side chain CH3 group (S2axis) for three 
ligation states. 
Coloring: apo (red), Cu1 (blue) and Cu2 (green). The position of each CH3 group is 
highlighted using a sphere on the apo-sCupA structure. M28, which is close to the 
N-terminus, is used as a proxy for disordered region while M91, which is stabilized 
by interactions with surrounding residues, is viewed as ordered regions.  
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These structural and dynamics studies reveal that the S1 and S2 Cu sites are 
characterized by distinct conformational dynamics, with the high affinity S1 site pre-
organized to bind Cu, while the low affinity, more solvent exposed Met-rich S2 is highly 
mobile in the apo-state.  Previous NMR studies show that the Cu bound to the S2 site is 
preferentially transferred to the S1 site of the CopAMBD.132 A pre-organized S1 site would 
lower the reorganizational energy likely resulting in a fast on-rate while prohibiting Cu(I) 
release.  In contrast, Cu(I) binding to the S2 site would be entropically disfavored, 
perhaps contributing to the substantially lower affinity; on the other hand, the side chain 
dynamics of M113 and M115 are not entirely quenched, and these residual dynamics may 
well facilitate Cu transfer.  These studies make the prediction that the S1 site may be 
principally involved in chelating Cu(I) at lower bioavailable [Cu], while S2 is largely 
responsible for transferring Cu(I) to CopA for export.   
3.3.3 Differential biological functions for each Cu binding site in CupA   
To test the hypothesis of the functionality of each Cu site in CupA, each Cu(I) site 
was disrupted by site directed mutagenesis, mutant bacterial strains prepared and tested 
for biological copper resistance.  A C111S CupA substitution is postulated to abrogate 
Cu(I) binding to the S1 site, will maintain a functional S2 site.  In contrast, the double 
mutant M113A/M115A CupA (CupA2MA) was designed to block binding to the S2 site, 
without disruption of the S1 site.  Anaerobic Cu(I) binding chelator competition 
experiments were carried out with each mutant to determine Cu(I) stoichiometry and 
affinity (Table 6).  Both mutant CupAs bind a single mol•equivalent of Cu(I) with the 
results consistent with retention of the desired sites.  In the case of CupA2MA, log KCu is 
17.2 (±0.1) or KCu within a factor of five of the S1 site in wild-type CupA.  In contrast, 
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for C111S CupA, log KCu is 12.5 (±0.3) or KCu ≈200-fold weaker than for the S2 site in 
wild-type sCupA.  This reveals that filling of the S1 site with Cu(I) clearly enhances the 
stability of the S2-Cu(I) complex.  Interestingly, both 1H,15N-HSQC and  1H,13C-HSQC 
spectra in Cu(I)-loaded C111S sCupA exhibit features of chemical exchange broadening 
in the7-8 loop region and beyond, and thus do not provide clear evidence for Cu(I) 
ligation by M113 and M115 in the C111S mutant (Fig. 37).   Substitution of immediately 
adjacent M116 and H117 with Ala does little to quench these dynamics, suggesting that 
non-native S2 Cu(I) coordination by these side chains is not the origin of this broadening 
(Fig. 38). Interestingly, it is possible to stoichiometrically oxidize the C74-C111 dithiol 
pair in apo-sCupA with two mol•equivalents of Cu(II) (Fig. 39a). In this case a 
downfield shift of the M113/M115 pair is observed (Fig. 39b).  We conclude from these 
experiments taken collectively that C111 plays a structural role in stabilizing the structure 
and quenching conformational dynamics of the S2 site.  
 cupAC111S and cupA2MA mutants S. pneumoniae D39 strains were prepared next 
and the Cu(I)-sensitivity of these strains were compared relative to the wild-type and 
∆cupA strains (Fig. 40).  Previous studies showed that 0.2 mM Cu added to the BHI 
growth medium was sufficient to completely inhibit growth by the ∆cupA mutant (Fig. 
40).  Remarkably, the cupAC111S strain is indistinguishable from the wild-type strain 
under these conditions revealing that the S1 site is dispensable for resistance of chronic 
Cu toxicity.  In contrast, the cupA2MA strain exhibits a severe growth phenotype, but 
grows slightly better than the ∆cupA strain under low copper stress (0.1 mM) (Fig. 40).   
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Figure 37: NMR spectra of apo-sCupAC111S and Cu1-sCupAC111S.  
(a) 1H,13C-HMQC spectra overlay of apo-sCupAC111S and Cu1-sCupAC111S. (b)1H, 
15N-HSQC spectra overlay of apo-sCupAC111S and Cu1-sCupAC111S. 
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Figure 38: 1H,13C-HMQC spectra of apo-sCupAC111SM116AH117A and Cu1-
sCupAC111SM116AH117A  
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Figure 39: Apo-sCupA is stoichiometrically oxidized by two mol•equivalents 
Cu(II) concomitant with the binding of Cu(I) to the partially oxidized S2 metal 
site.   
(a) Anaerobic titration of Cu(II) into apo-sCupA in the presence of excess BCS 
carried out essentialy as previously described for E. coli multiple antibiotic 
regulator (MarR).159 Two mol•equiv of Cu(II) result in two mol•equiv of Cu(I) 
as detected by binding by BCS via absorbance at 483 nm and stoichiometric 
C74-C111 disulfide bond formation as determined by no residual reactivity 
toward dithiodinitrobenzoic acid (DTNB).  The blue and red arrows represent 
samples subjected to 1H,13C HMQC analysis (b), and reveal that even under 
conditions in which all Cys are oxidized, sCupA is still capable of binding Cu(I) 
to the modified S2 site. As evidenced by the downfield shift in the Met methyl 
protons (red box).132   
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The reduced growth rate of the cupA2MA strain is the result of copper toxicity as 
shown by elevated cell-associated copper, in contrast to the cupAC111S strain which is 
characterized by similar total cell associated Cu under conditions of 0.2 mM Cu-shock, 
relative to the wild-type D39 strain (Fig. 41).  These data reveal that the S2 Met-rich site 
Cu site is necessary and sufficient for cellular Cu resistance.  In addition, they reveal that 
despite the fact that this S2 site in the cupAC111S strain is of substantially lower Cu affinity 
and enhanced conformational dynamics, it is capable of functioning like a wild-type S2 
chelate in cellular Cu resistance.  These studies support the hypothesis that the S2 site of 
CupA is primarily involved in Cu transfer to CopA for efflux and thus is essential in Cu 
resistance.  In contrast, the high affinity S1 site is only involved in chelating cellular 
Cu(I), and plays no role in mitigating the effects of Cu(I) toxicity.  The S1 site may have 
a role in buffering low levels of free Cu, like previously attributed to other bacterial 
chaperones, thus effectively tuning the sensitivity of the cellular Cu response.92  
3.3.4 Oxidation state of CupA in cells  
One possible explanation for the fact that the S1 plays little if any role in Cu 
resistance is that the C74-C111 pair is oxidized under the microaerophilic growth 
conditions used here.  Under these conditions, S. pneumoniae respires by generating 
millimolar hydrogen peroxide as a result of the action of two enzymes, lactate oxidase 
and pyruvate oxidase.  A major modification of H2O2 is sulfenylation of cysteine 
thiols133, which allowed to occur on CupA, would likely lead to C74-C111 disulfide bond 
formation. We first measured the redox potentials of both sCupA and the CopAMBD using 
a simple GSH:GSSG titration and measured the extent of reduced thiols by reacting the 
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reaction mixture with EZ-link-PEG11 conjugate, and running the products on a 
denaturing, non-reducing polyacrylamide gel.   
 
 
 
Figure 40: Growth rate analysis of strains encoding CupAC111S or CupA2MA in 
BHI media in various Cu stress conditions.  
0.1 mM Cu is viewed as moderate level of stress and 0.2 mM is considered to be 
severe level of stress. Experiment was carried out by Yue Fu and Kevin Bruce 
from Winkler Lab in the Department of Biology. 
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Figure 41: Total cell associated Cu measurement for different cupA WT and 
mutant strains.  
(a) Cell growth scheme for Cu content measurement. (b) Total cell associated Cu 
content for each strain in the absence and presence of Cu stress. Cells subject to 
measurement were harvested as shown in (a).  Experiment was carried out by 
Kevin Bruce from Winkler Lab in the Department of Biology. 
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Figure 42: Redox potential measurement for (a) apo-sCupA and (b) apo-
CopAMBD.  
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Both sCupA and CopAMBD exhibit nearly identical redox potentials, Eo’, of ≈–123 
mV (Fig. 42).  Although the cytoplasmic redox potential of S. pneumoniae D39, or that 
close to the inner leaflet of the plasma membrane, are not known, each of these potentials 
is strongly positive relative to previously characterized copper chaperones, e.g., human 
Atox1134, consistent with the hypothesis that sCupA is likely to be fully reduced in 
pneumococcal cells.   
 To test this, a standard in situ thiol-labeling experiment was adapted by treating 
cell extracts derived from cells expressing FLAG-tagged CupA stressed with 0.2 mM Cu 
with 4-acetamido-4'-maleimidylstilbene-2,2'-disulfonic acid (AMS), running them out on 
gels and probing these gels with anti-FLAG antibodies (Fig. 43).2  These experiments 
reveal that CupA is largely reduced in cells (ranging from 85-100% in multiple 
experiments) in the presence of Cu stress (0.2 mM Cu) (Fig. 43, lane 3), relative to 
controls for the reduced (pretreatment with the reducing agent, TCEP) (Fig. 43, lane 4) 
and oxidized (pretreatment with 0.2 mM 4,4’-dithiopyridine or 4,4’-DPS) (Fig. 43, lane 
5) CupAs.  Note that when wild-type cells are cultured with 0.2 mM DPS prior to 
harvest, this results in oxidation of ≈50% of the CupA under these conditions (Fig. 44b, 
insert last lane).  This significant level of oxidation (50%) of CupA induces no growth 
phenotype (treatment with DPS alone also induces no growth phenotype under these 
conditions).  In contrast, a strong growth phenotype is observed for the cupA2MA strain 
when subjected to the same copper shock with 0.2 mM Cu in the presence of DPS vs. Cu- 
or DPS-treatment alone (Fig. 44a).   
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Figure 43: Free thiol labeling with CupA. 
(a) in situ thiol-labeling experiment for CupA protein. Oxidized and reduced 
control were prepared using 4-DPS or TCEP treatment respectively. (b) and (c) 
chemical structure of DPS and AMS used in (a). Experiment was carried out by 
Yue Fu and Kevin Bruce from Winkler Lab in the Department of Biology. 
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Figure 44: Growth rate analysis using copper and oxidative stress. 
(a) Growth rate analysis of cupA2A mutant strain in the presence of 4-DPS and 
Cu. (b) Growth rate analysis of cupA WT strain in the presence of 4-DPS 
treatment. Insert, in situ thiol-labeling experiment for CupA under oxidant 
treatment before harvesting. Experiment was carried out by Yue Fu and Kevin 
Bruce from Winkler Lab in the Department of Biology. 
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These findings taken together suggest that the CupA dithiol pair is not 
significantly oxidized in cells, but if this occurs by treatment with the strong oxidant 
DPS, cellular Cu resistance mediated by CupA is refractory to CupA oxidation, but only 
if a functional S2 site is lost.  Further, these results are also consistent with a buffering 
role for the S1 site that only becomes apparent when the S2 site is inactivated (Fig. 44a).  
3.3.5 A heterologous copper chaperone expressed and localized to the plasma 
membrane does not provide cellular copper resistance 
The results above reveal the functional primacy of the CupA S2 site in mediating cellular 
Cu resistance, with the hypothesis that CupA transiently docks with CopA, and via 
intermolecular transfer mediated by ligand exchange, to facilitate Cu efflux from the cell.  
This protein-protein interaction model makes the prediction that a non-cognate Cu 
chaperone may not support robust cellular Cu resistance, and that there exists site on 
CopA that mediates intermolecular Cu transfer that is distinct from the N-terminal MBD.  
While CopAMBD is capable of stripping Cu from the S2 site of CupA, this transfer 
reaction is not required for cellular Cu resistance since the copAC49S strain exhibits wild-
type Cu resistance.132  To test this, we first prepared a mutant strain designed to express a 
chimeric Bacillus subtilis CopZ (CopZBsu), which harbors the N-terminal transmembrane 
helix of CupA and full-length CopZBsu.  We note that CopZBsu is characterized by a high 
Cu(I) binding affinity comparable to S1 site of CupA.28  Growth curves of the chimeric 
strain reveals a severe growth phenotype under 0.2 mM Cu stress, despite the fact that the 
CopZ chimera is expressed to high levels, localizes to the plasma membrane, and is fully 
reduced in cells and thus would be capable of binding intracellular Cu (Fig. 45).  This 
mutant is functionally indistinguishable from the ∆cupA and cupA2MA strains, which is in 
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consistent with the hypothesis that there is a specificity of Cu trafficking at the plasma 
membrane in S. pneumoniae. 
 
 
 
Figure 45: Growth rate analysis of copZ chimeric strain. 
(a) in situ thiol-labeling experiment for TMcupA-CopZ protein. (b) Growth rate 
analysis of TMcupA-CopZ strain under Cu stress. The chimeric protein is 
illustrated in the cartoon representation. Although both Cys residues are 
reduced, the chimeric protein has little effect on copper resistance. Experiment 
was carried out by Kevin Bruce from Winkler Lab in the department of 
biology. 
 
105 
 
3.3.6 The metal binding site or entry site on CopA is required for Cu resistance at 
high Cu 
Previous crystallographic studies of Legionella pneumophila CopA in the apo-
state revealed a trio of highly conserved, cytoplasmic-facing residues corresponding to 
M172, E216 and D347 in S. pneumoniae CopA positioned just above the inner leaflet of 
the plasma membrane and the “platform helix”, corresponding to the C-terminal half of 
kinked MB helix unique to Cu/Zn P1B ATPase transporters.67  In an archeal CopA, this 
entry metal binding site (MBS) was shown to be required for cognate Cu(I)-CopZ-
stimulated CopA ATPase activity and Cu(I) transfer, but was not required for free Cu(I)-
stimulated activity, consistent with the interpretation that the MBS specifically provides a 
docking site copper chaperone-mediated Cu delivery.72 We therefore prepared a strain 
encoding a FLAG-tagged triple Ala substitution mutant of copA, M172A/E216A/D347A, 
denoted copA∆MBS in a C49S CopA background and tested the viability of this strain at 0, 
0.2 and 0.5 mM Cu added to the BHI medium (Fig. 46).  As can be seen, although this 
strain grows with no clear growth phenotype at 0.2 mM Cu relative to the parent copAC49S 
strain, it nearly fails to grow at 0.5 mM Cu.  These data are consistent with the hypothesis 
that the MBS provides a docking site for CupA in mediated extracellular Cu(I) efflux.72        
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Figure 46: Growth rate analysis of copAMBS strain in various Cu stress conditions.  
Three different extracellular Cu concentration were used: 0 mM, 0.2 mM and 0.5 
mM. copAMBS strain shows growth phenotype only under 0.5 mM Cu. Experiment 
was carried out by Kevin Bruce from Winkler Lab in the Department of Biology. 
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3.4 Implication of the work 
 This work provides new insights into the mechanism of cellular Cu resistance in 
the Gram-positive respiratory pathogen, S. pneumoniae, and builds on previous structural 
studies of the novel, membrane-anchored cupredoxin fold chaperone, CupA. We present 
the solution structure of metal-free apo-sCupA and show that it adopts a structure that is 
essentially identical to that of Cu2-sCupA, with the exception of residues 112-116, which 
are highly dynamic in the both the backbone and the side methyl groups of the S2-
coordinating methionines, M113 and M115.  In contrast the high affinity S1 Cu site is 
essentially pre-organized, filling of which quenches backbone disorder but enhances side 
chain dynamics, which collectively increase the S2 site binding Cu(I) binding affinity.  
The S2 Cu site in CupA is necessary and sufficient for resistance against chronic Cu 
toxicity, while the S1 site is largely dispensable for this activity.  Although the di-thiol 
C74-C111 pair in CupA is reduced in cells under Cu stress, oxidation to an 
intramolecular disulfide bond retains Cu(I) binding to the S2 site, and this oxidation in 
the cell has little effect on cellular Cu resistance provided a functional S2 site is present 
in CupA.  The S1 site provides some protection against Cu toxicity, and may well 
function to buffer very low levels of Cu in the absence of significant Cu stress.  Finally, 
two lines of evidence were presented which are in consistent, albeit not confirmatory, 
with the hypothesis that CupA S2-mediated Cu transfer to CopA is on pathway for Cu 
efflux, and this requires structural integrity of the CupA S2 and CopA MBS Cu sites, 
which is in contrast to the N-terminal MBD which is seemingly not required for this 
function. 
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 There is speculation that the Cu(I) binding affinity of the copper-sensing repressor 
CopY and the copper chaperone CupA, when expressed as equilibrium dissociation 
constants, 1/KCu, provide a threshold [Cu]free, below which pneumococcal cells buffer 
free Cu, and above which, the CopY-induced expression of the cop operon is induced to 
effect cellular Cu(I)-resistance.  In this model, this set point might be set to ≤10-16 M Cu, 
corresponding to the affinity of CopY for Cu(I) (see chapter IV, Fig. 49), which is then 
bound by both Cu sites in CupA as soon as  [Cu]free exceeds ≈10-14 M, which corresponds 
to the Cu concentration where virtually all CupA sites would be bound, poised to 
facilitate Cu efflux from the cell.  The characterization of the cupAC111S strain suggests 
that [Cu]free 100-fold higher provides full protection against Cu toxicity.  Thus, based on 
KCu values measured for other bacterial Cu chaperones, S. pneumoniae would appear to 
be more tolerant of low levels of bioavailable Cu, and this might be the primary role 
played by the S1 Cu site in CupA.  We emphasize, however, that a KCu of 1012 M-1 is 
clearly not all that is required since the C74S CupA mutant (which disrupts Cu binding to 
both S1 and S2 sites) retains a non-native Cu-binding site of 1012 M-1 affinity, but is as 
sensitive to Cu stress as a ∆cupA strain (table 6).               
 These findings suggest that the Met pair in the S2 Cu site optimizes the dynamics, 
rather than the stability, of the site in a way that kinetically facilitates intermolecular Cu 
transfer to the MBS, which is on pathway for Cu efflux.61,72  Intermolecular Cu transfer 
via ligand exchange at the S2 site is plausible given the fact this site is at the protein 
surface, and is clearly capable of adding a fourth ligand from CopA to initiate Cu 
transfer, as exemplified by coordination of Cl–  or Br– in NaCl or NaBr-containing 
solutions, respectively.132  Although M116 is not conserved in CupAs, H117 is, which 
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suggests the possibility that residues beyond the S2 Mets and the CopA MBS are required 
for Cu transfer.   
 
Table 5: NMR structural statistics for apo_sCupA. 
    
Conformationally-restricting experimental constraints a    
   NMR distance and dihedral constraints    
      NOE-based distance constraints    
         Total NOE  2201  
         intra-residue (|i - j| = 0)  347  
         sequential (|i – j| = 1)  539  
         medium range (1 < |i – j| < 5)  248  
         long range (|i – j| ≥ 5)  1067  
         NOE constraints per restrained residue b  23.9  
      Dihedral-angle constraints    
           ° )  65  
          ° )  65  
      Total no. of restricting constraints b  2331  
      Total no. of restricting constraints per restrained residue b 25.3  
      Restricting long-range constraints per restrained residue b 11.6  
Residual constraint violations a, c    
   Average no. of distance violations per structure    
      0.1 – 0.2 Å  5.5  
0.2 – 0.5 Å  0.44  
      > 0.5 Å  0  
      Maximum distance violation (Å) d  0.35   
   Average no. of dihedral angle violations per structure    
      1 – 10 °  0.83  
      > 10 °  0  
      Maximum dihedral angle violation (°) d  1.70   
RMSD Values    
   Backbone atoms (Å) e  0.1   
   Heavy atoms (Å) e  0.6  
Ramachandran plot statistics e    
   Most favored regions (%)    90.7  
   Allowed regions (%)  9.3  
   Disallowed regions (%)  0  
Global quality scores     
 Mean score SD Z-scoref 
   Procheck G-factor (e -0.66 N/A -2.28 
   Procheck G-factor (all) e -0.81 N/A -4.79 
   Verify3D 0.43 0.0244 -0.48 
   ProsaII (-ve) 0.45 0.0315 -0.83 
   MolProbity clashscore 12.99 1.7223 -0.70 
BMRB accession no.  25098  
PDB ID code  2MRY  
a Analysed for residue 26 to 123                                                                                                        
b There are 92 residues with conformationally restricting constraints                                                                 
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c Calculated for all constraints using sum over r-6 (Generated using PSVS 1.5135–140)                                         
d Largest constraint violation among all the reported structures                                                                        
e Ordered residue range 30 – 111, 117 – 122 [S() + S () ≥ 1.8]                                                         
f With respect to mean and standard deviation for a set of 252 X-ray structures of < 500 
residues with resolution ≤ 1.80 Å, R factor ≤ 0.25 and Rfree ≤0.28; a positive value 
indicates a ‘better’ score (Generated using PSVS 1.5)                                                                                         
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Table 6: Cu(I) binding affinities of wild-type sCupA and sCupA mutantsa  
 
Protein log KCu1S1 (M-1) log KCu2S2 (M-1) 
sCupA 17.9 (±0.3) 14.8 (±0.2) 
C111S sCupA – 12.5 (±0.3) 
C74S sCupA – 12.5 (±0.2) 
M113A/M115A sCupA (2MA) 17.2 (±0.1) – 
aMeasured using a global fit to a series of anaerobic chelator competition 
assays as described previously132.  Conditions: 25 mM HEPES, pH 7.0, 200 
mM NaCl, ambient temperature. 
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Chapter IV: Characterization of Cu(I)-specific regulator CopY in S. pneumoniae 
4.1 Introduction 
CupA and CopA from S. pneumoniae are under the regulation of the 
transcriptional regulator CopY. CopY represents a family of copper specific 
metalloregulatory proteins, founding member of which was characterized in 
Enterococcus. hirae.47 CopY contains a N-terminal DNA binding domain and a C-
terminal copper binding domain. Based on sequence similarity of the N-terminal DNA 
binding domain, it is proposed to be a member of MecI/BlaI family proteins.86 In E. 
hirae, CopY regulates the copYZBA operon which encodes two Cu(I) specific P1B type 
ATPase CopA and CopB, a cytoplamic Cu(I) chaperone CopZ and CopY itself. Zn(II) 
bound CopY was proposed to bind to the operator-promotor region of the copYZBA 
operon to repress the transcription in vitro.89 CopZ in E. hirae has been proposed to 
deliver Cu(I) to Zn(II) bound CopY and convert it into Cu(I) bound CopY, which then 
dissociate from the DNA binding region (the cop box), allowing transcription of 
downstream genes in the copYZBA operon. Based on multiple sequence alignment (Fig. 
47), most CopY proteins contain a CXXC…CXXC motif at the extreme of the C-
terminal regulatory domain. This has been shown to form a highly luminescent binuclear 
S4-Cu2 cluster demonstrated in previous spectroscopic studies of E. hirae CopY141, with 
the Cu(I) binding stoichiometry of 2Cu(I) per CopY. Howeer, the regulatory function of 
each Cys residue has not been clearly detailed. The NMR solution structure of the N-
terminal DNA binding domain of CopR, a CopY family copper specific regulator found 
in Lactococcus lactis IL1403, provides insights into the structure of CopY family 
protein.142 The monomer domain reveals a winged helix-turn-helix domain with high 
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structural similarity to the DNA binding domain of S.aureus MecI and BlaI.86 However, 
there is yet little details on the structure of intact CopY.  
In Streptococcus pneumoniae, CopY regulates the cop operon, encoding CopY, 
CupA and CopA.132 Transcriptional analysis by real time quantitative qRT-PCR and 
assaying strains with copY-lacZ fusion demonstrate that the cop operon is autoregulated 
by copper-specific regulator CopY.1 However, the details of regulatory mechanism of 
CopY in pneumococcus remain unclear. For example, whether Zn(II) functions as an co-
repressor while Cu(I) functions as an allosteric inhibitor of DNA/protein binding is not 
clear. In this chapter, preliminary characterization of Spn CopY is presented, including  
Zn(II) and Cu(I) binding affinities of CopY and initial NMR study on apo, Zn and Cu(I) 
bound form of intact CopY/regulatory domain of CopY.  
4.2 Methods 
4.2.1 Protein expression and purification  
The pHis plasmid was used to subclone CopY from S.pneumoniae D39 strain 
(SPD_0633).  This vector encodes a His6 tag and TEV protease cleavage site at the N 
terminus to yield, following cleavage, three non-native N-terminal amino acids of the 
sequence GAM for CopY as described for sCupA.132 BL21 (DE3) competent cells were 
transformed with the resultant plasmid.  For unlabeled proteins, an overnight culture of E. 
coli. cell was inoculated into Luria Broth (LB) media containing 100 μg/mL ampicillin. 
For the 13C,15N-labeled proteins, an overnight culture of E. coli. was inoculated into M9 
minimal media (pH 7.4) containing 100 μg/mL ampicillin, supplemented with 15NH4Cl (1 
g/L) (Cambridge Isotope Laboratories) and [13C6]-D-glucose (2.5 g/L) (Cambridge 
Isotope Laboratories). For both media, the cells were grown at 37 °C to OD600 = 0.6. 
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Isopropyl β-D-thiogalactopyranoside (IPTG) was then added to a final concentration of 1 
mM and cultures were continued at 16 °C for 20 h.  The cells were harvested by 
centrifuging and stored at -80 °C.  All the buffers in the purification were degassed and 
refilled with Argon using a Schlenk line just prior to use.  To break the cells, the cells 
were resuspended in buffer R (25 mM Tris, pH 8.0, 200 mM NaCl, 5 mM TCEP).  The 
resuspended cells were lyzed by a sonic dismembrator (Fisher).  The recombinant 
proteins were purified using HisTrap FF columns (GE Healthcare) using a gradient of 
imidazole from 10 mM to 300 mM in buffer R.  The appropriate fractions were pooled 
and subjected to TEV protease cleavage at for 16 °C for 36 h. The proteins were further 
purified using HisTrap FF columns (GE healthcare) and Superdex 75 16/60 column (GE 
healthcare).  The purity of the proteins was estimated to be >95 % as judeged by SDS-
PAGE and ESI-MS.  Protein concentration was determined by A280 with an extinction 
coefficient of 18240 M-1cm-1 on an UV-visible spectrometer (HP/Agilent 8453).   
4.2.2 Cu(I) Binding Affinity Measurements 
Bathocuproine disulfonate (BCS) was used for Cu(I) binding affinity 
determination of CopY.  All proteins for binding experiments were buffer exchanged 
from protein stock to the degassed buffer B (25 mM HEPES, pH 7.0, 200 mM NaCl) in 
an anaerobic glove box.  Cu(I) stock was prepared by taking the supernatant from the 
mixture of  CuCl powder with fully degassed buffer B (25 mM HEPES, pH 7.0, 200 mM 
NaCl). The accurate concentration of Cu(I) stock was determined by Atomic Absorption 
Spectroscopy with a general concentration around 10 mM. The final titration solution 
contains 20 or 30 μM Cu(I) and 60 or 90 μM BCS in Buffer B. Each 120 μL aliquot of 
titration solution was mixed with increasing CopY titrant.  Optical spectra of BCS were 
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recorded from 200 nm to 900 nm. Corrected spectra were obtained by subtracting 
baseline spectrum from each CopY-addition spectrum and then corrected for dilution. 
A483 was used to determine the concentration of Cu2-BCS complex using an extinction 
coefficient of 13500 M-1cm-1.  All the data were fitted to the appropriate competition 
model using Dynafit113.   
4.2.3 Intial NMR study on CopY  
Typical NMR sample solution conditions were 300-600 μM CopY protomer, 
15N/13C-labeled CopY in 50 mM potassium phosphate pH 7.0, 200 mM NaCl, 0.02% 
(w/v) NaN3 and 10% (v/v) 2H2O. All  NMR samples were prepared in an anaerobic glove 
box. Apo-CopY was prepared with 5 mM TCEP. Varian DDR 800 and 600 MHz 
spectrometers equipped with cryogenic probes in the METACyt Biomolecular NMR 
Laboratory were used to acquire data for CopY samples. NMR data were processed using 
NMRPipe103 and were analyzed using Sparky104 and CcpNmr Analysis105. All spectra 
were acquired at 30 °C. Chemical shift is referenced relative to 2,2-dimethyl-2-
silapentene-5-sulfonic acid (DSS). 
4.3 Results  
4.3.1 Copper and Zinc binding affinities of Spn CopY  
A multiple sequence alignment shows CopY from S. pneumoniae has sequence 
similarity with characterized CopY from E. hirae and CopR from L. lactis (Fig. 47). 
However, Spn CopY only contains 2 of the 4 conserved Cys residues near the C terminus, 
which has been shown to form a highly luminescent binuclear S4-Cu2 cluster in other 
CopY proteins.143 The impact of a lack of two of the four Cys residues on the metal 
binding affinities and geometry of Spn CopY was therefore of interest. Spn CopY still 
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binds Zn(II) with high affinity (Fig. 49) with the stoichiometry of CopYdimer: Zn(II) to be 
1:1. Only  a lower affinity can be obtained for Kzn with this condition. With additional 
experiments using higher affinity chelators, detailed Zn binding affinities can be 
measured. A BCS competition assay was employed to measure the Cu(I) binding affinity 
of Spn CopY(Fig. 48). Based on three titrations, Spn CopY binds to Cu(I) with a 
stoichiometry of CopYdimer:Cu(I) to be 1:2 with an affinity of 11.06.16log  MKCu  
(Fig. 48). The binding affinity for Cu(I) of CopY is about two magnitude lower than 
those previeously described  Cu(I)-specific transcriptional regulators, CsoRs and 
CueR.48,49 
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Figure 47: Multiple sequence alignment of CopY from different bacteria.  
The conserved Cys residue proposed involved in copper and zinc binding are 
highlighted with asterisk. Note S. pneumoniae CopY only contains two of the four 
Cys residues near C terminus.  
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Figure 48: Binding curves obtained from anaerobic Cu(I) chelator competition to 
measure Cu(I) binding affinity of CopY.  
The experiments were carried out by titrating apo CopY into a mixture of Cu(I) 
and BCS at pH 7.0. Three individual experiments were carried out for BCS 
assay. Closed symbols represent A483 values for the Cu(I)-(BCS)2 complex.  The 
continuous line represents the results of a global analysis of all experiments to 
the same model. Red: 22 μM CuCl and 60 μM BCS; Green: 25 μM CuCl and 75 
μM BCS; Blue: 29 μM CuCl and 90 μM BCS. Cu(I) binding affinity of CopY 
was extracted from all three experiments and is shown at the top of the figure.  
Hendrik Glauninger performed the titrations shown in this figure under the 
instruction of Yue Fu.  
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Figure 49: Binding curves obtained from zinc chelator competition to measure 
Zn(II) binding affinity of CopY. 
The experiments were carried out by titrating Zn(II) into a mixture of apo CopY 
and MF2 at pH 7.0. Closed symbols represent A366 or A325 values for the Zn(II)-
MF2 complex.  The continuous line represents the results of the analysis of the 
experiments to the binding model. Red: A325 values; Blue: A366 values; For the 
experiment in the figure, the mixture contains 12 μM CopYdimer and 16 M MF2. 
Zn(II) binding affinity of CopY was extracted from the experiment and is shown 
in the figure. 
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4.3.2 Initial NMR study on Spn CopY  
There are no structures available for any full length CopY, with the only high 
solution resolution structure of the N-terminal DNA binding domain of L .lactis CopR.142 
Efforts were made towards characterizing the C-terminal metal binding domain (residue 
68-131) as well as full length Spn CopY structurally using NMR spectroscopy. 1H, 15N-
HSQC spectra of apo, Zn(II) loaded and Cu(I) loaded CopY68-131 reveal far few cross-
peaks than expected based on the actual number of residues in CopY68-131, thus giving 
little structural information (Fig. 50). 1H, 15N-HSQC spectra of full length Spn CopY in 
the Zn(II)-loaded state gives by far the most cross-peaks (Fig. 51b), but the relative 
intensity of the cross peaks vary substantially, indicative of conformational dynamics in 
certain regions of the molecule. One possibility is that the conformational dynamics 
would be quenched further by forming Zn(II)-CopY: DNA complex. However, a 
preliminary experiment shows that the complex gives far few cross peaks compared to Zn 
state CopY. Given that, it is difficult to extract useful structure data from NMR based 
experiment.  
4.4 Summary 
 We characterized the copper and zinc binding affinities of Spn CopY. Spn CopY 
binds up to one molar equivalent of Zn(II) or up to two molar equivalents of Cu(I) per 
dimer, respectively. The Cu(I) binding affinity of Spn CopY, although lower than the 
affinities measured in other Cu(I)-specific regulators, agrees with the “threshold” model 
proposed in Chapter III.  Work is underway to characterize the DNA binding properties 
of apo, Zn(II) or Cu(I) loaded Spn CopY as well as various mutants, which will provide 
information about the mechanism of transcriptional regulation by CopY.  
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Figure 50: 1H, 15N-HSQC spectra of different metallated states of the C-terminal 
metal binding domain of CopY (CopY68-131). Protein concentration ~ 300 M. nt 
=16, ni =128. Buffer as described in the material and methods.  
(a) 1H, 15N-HSQC spectra of apo CopY68-131; (b) 1H, 15N-HSQC of fully Zn(II) 
loaded CopY68-131; (c) 1H, 15N-HSQC spectra of fully Cu(I) loaded CopY68-131.  
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Figure 51: 1H, 15N-HSQC spectra of different states of CopY. Protein concentration ~ 
400 M. nt =16, ni =128. Buffer as described in the material and methods. The DNA 
promoter sequence is 5’-GTTCTATAATT TACA AT TGTA AATTATAGAAC-3’. 
(a) 1H, 15N-HSQC spectra of apo CopY; (b) 1H, 15N-HSQC of fully Zn(II) loaded 
CopY; (c) 1H, 15N-HSQC spectra of fully Zn(II) loaded CopY-DNA promoter ternary 
complex.  
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Chapter V: Future work and Perspectives 
There are two major unsolved issues regarding the mechanisms of the copper 
resistance in pneumococcus and in bacteria as a whole. The first one is the understanding 
of the details on copper transfer mechanism from copper chaperone to exporting P1B type 
ATPase. The CupA-CopA system in pneumococcus provides an ideal platform for 
investigating the transfer mechanism. The initial question we have to address is that 
whether there is direct protein-protein interaction between CupA and CopA in the cell 
membrane. One hypothesis is that the interaction is dependent upon the charge 
complementarities between regions around S2 site in CupA and the regions around the 
putative Cu entry site in CopA. Potential charged residues around Cu entry site in CopA 
are proposed to be involved in facilitating protein-protein interaction between CupA and 
CopA, which may be essential for the  productive Cu transfer. Based on the homology 
model of CopA from the known CopA crystal structure, the potential Cu entry site for 
Spn CopA is composed of M172, E216 and D347. There is a ring of positively charged K 
and R residues around the entry site including: R102, K103, and R110 from the N-
terminus of CopA; K155, K166 and K167 from the platform helix of CopA; K221, K229, 
K333, K334 and R339 from the Nucleotide binding domain (N domain) of CopA. 
Pneumococcal strains with CopA charge residue mutant can be constructed and growth 
rates analyzed will be performed in the absence and presence of Cu stress to test the 
essentiality of these electrostatic interactions. Efforts are also underway in an effort to 
trap wild-type and potentially longer-lived CupA-CopA complexes by covalent 
crosslinking in vivo.  
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Once an physical interaction between CupA and CopA is demonstrated, the next 
question of interest would be the factors that influence the Cu transfer rate between CupA 
and CopA. The most fruitful would be to biochemical purify full length CupA and CopA 
and reconstitute them into liposome to enable either ATPase activity measurement or 
fluorescent based Cu transfer rate analysis across the membrane. 
The second major question remaining is whether there is interplay between Cu 
resistance system and bacterial cellular redox homeostasis system, which are intrinsically 
linked by sulfur chemistry.2,144  Glutathione and perhaps other related low molecular 
weight thiols (LMWTs) in bacterial pathogens that lack glutathione, e.g., bacillithiol and 
mycothiol in S. aureus and M. tuberculosis, respectively, likely help to buffer “free” 
Cu(I) to very low levels given their high affinity for Cu(I)27, since in some116 but not all57 
cases, crippling glutathione biosynthesis is synergistic with the deletion of the copper 
chaperone with respect to Cu(I) stress resistance.  Likewise, in S. pneumoniae, abrogation 
of the ability to uptake glutathione (pneumococcus does not biosynthesize GSH) gives 
rise to a severe growth defect under copper stress.58  These studies thus generally link the 
redox status of the cytoplasmic compartment as defined by the GSH/GSSG couple to 
copper homeostasis and resistance.144 
 Further, in mammalian cells, it has been demonstrated that the reduced cysteines 
in Atox1 are responsible for coordinating Cu(I), the redox state of those cysteines is also 
maintained through equilibrium with GSH/GSSG pair in human cells.2  Atox1, in turn, 
may functionally replace GSH under conditions of low total glutathione, consistent with 
the original functional description of Atox1 as an antioxidant protein.2  Further, human 
glutaredoxin 1 (hGrx1) has been shown to catalyze the interchange between disulfide-
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oxidized and reduced Atox1 as a function of the GSH/GSSG ratio.144  In vitro 
experiments also demonstrate that hGrx1 binds Cu(I) with high affinity, indicating a 
potential role in Cu(I) buffering.144  The dual roles of GSH, Atox1 and Grx1 in cellular 
redox and copper homeostasis strongly suggest a functional linkage between these two 
systems in higher eukaryotes. Future studies that define the chemical and physical origins 
of this linkage and more generally, how copper stress impacts other kinds of thiol 
chemistry in bacteria that might be manifest in a typical antimicrobial host response, 
promises new surprises at the host-pathogen interface.  
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Appendix 
Appendix I Assignments of backbone resonances of extracellular loop 1 of FtsX 
(FtsXECL1) from S. pneumoniae 
Methods 
Protein expression and purification The pHis plasmid was used to subclone FtsXECL1 
(residues  47-168 of full-length FtsX) This vector encodes a His6 tag and TEV protease 
cleavage site at the N terminus to yield, following cleavage, three non-native N-terminal 
amino acids of the sequence GAM for FtsXECL1 (denoted residues 26-28 in the structure). 
BL21 (DE3) competent cells were transformed with the resultant plasmids.  For 
unlabeled proteins, an overnight culture of E. coli. cell was inoculated into Luria Broth 
(LB) media containing 100 μg/mL ampicillin. For the 15N/13C labeled proteins, an 
overnight culture of E.coli. cells was inoculated into M9 minimal media (pH 7.4) 
containing 100 μg/mL ampicillin, supplemented with 15NH4Cl (1 g/L) (Cambridge 
Isotope Laboratories) and [13C6]-D-glucose (2.5 g/L) (Cambridge Isotope Laboratories).  
For both media, the cells were grown at 37 °C to OD600 = 0.6. Isopropyl β-d-
thiogalactopyranoside (IPTG) was then added to a final concentration of 0.4 mM and 
cultures were continued at 16 °C for 20 h.  The cells were harvested by centrifuging and 
kept at -80 °C.  All the buffers in the purification were degassed and refilled with Argon 
using a Schlenk line right before use.  To break the cells, the cells were resuspended in 
buffer R (25 mM Tris, pH 8.0, 200 mM NaCl, 5 mM TCEP).  The resuspended cells were 
lyzed by a sonic dismembrator (Fisher).  The recombinant proteins were purified using 
HisTrap FF columns (GE Healthcare) using a gradient of imidazole from 10 mM to 300 
mM in buffer R.  The appropriate fractions were pooled and subjected to TEV protease 
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cleavage at for 16 °C for 36 h. The proteins were further purified using HisTrap FF 
columns (GE healthcare) and Superdex 75 16/60 column (GE healthcare).  The purity of 
the proteins was estimated to be >95 % as judeged by SDS-PAGE and ESI-MS.  Protein 
concentration was determined by A280 with an extinction coefficient of 14440 M-1cm-1 
on an UV-VIS spectrometer (HP/Agilent8453).   
FtsxECL1 resonance assignment Typical NMR sample solution conditions were 500-
600 μM, 15N/13C-labeled FtsXECL1, pH 7.0, 50 mM potassium phosphate, 50 mM NaCl, 
0.02% (w/v) NaN3 and 10% (v/v) 2H2O. Varian 600 MHz spectrometers equipped with 
cryogenic probes in the METACyt Biomolecular NMR Laboratory were used to acquire 
data for FtsXECL1 samples.  NMR spectra were referenced to H2O. NMR data were 
processed using NMRPipe and was analyzed using Sparky and CcpNmr Analysis. All 
spectra were acquired at 25 °C. Sequential resonance assignments of FtsXECL1 were 
obtained using 1H-15N heteronuclear single quantum coherence (HSQC) spectra, along 
with triple resonance CBCA(CO)NH, NHCACB, HNCO, HNCA and HN(CO)CA 
spectra. Automatically backbone assignment server PINE108 was employed to help with 
the assignment. 
Results 
Complete backbone assignments of FtsXECL1 construct 
FtsX in involved in cell division complex formation in S. pneumoniae. Complete 
backbone H, N, CO, CA, CB resonance assignments were made for extracellular loop 1 
of FtsX (FtsXECL1) by using a series of triple resonance spectra (see methods for details). 
After obtaining full backbone assignment other than residue N85, Talos+ was used to 
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predict secondary structure of FtsXECL1 based on chemical shift and structure data in the 
database (Fig. 52). 
 
 
Figure 52: Backbone assignments labeled on 1H, 15N-HSQC spectra of FtsXECL1.  
Talos+ predicted secondary structure is plotted on the top.  
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Appendix II Backbone assignments of each metallation states 
 
 
Figure 53: Backbone assignment labeled on 1H, 15N-HSQC spectra of apo-sCupA. 
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Figure 54: Backbone assignment labeled on 1H, 15N-HSQC spectra of Cu1-
sCupA. 
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Figure 55: Backbone assignment labeled on 1H, 15N-HSQC spectra of Cu1-sCupA. 
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Figure 56: Backbone assignment labeled on 1H, 15N-HSQC spectra of apo-
CopAMBD. 
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Figure 57: Backbone assignment labeled on 1H, 15N-HSQC spectra of Cu1-
CopAMBD. 
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Figure 58: Backbone assignment labeled on 1H, 15N-HSQC spectra of Cu2-
CopAMBD. 
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Appendix III Sample Dyanfit script for Cu(I) binding affinity measurement.  
BCA binding experiments 
 
[task]  
data = equilibria 
task = fit 
[mechanism] 
cupa + cu <==> cupa.cu : k1 assoc. 
bca + bca + cu <==> bca2.cu : k2 assoc. 
[concentrations] 
[constants] 
k1 = 1e+3? 
k2 = 1.585e+5 
[responses] 
bca = 5.7e-5? 
bca2.cu = 0.0077 
[equilibria] 
variable cupa 
file ./data/CupAC111S/20131010.txt |concentration cu = 21, bca = 50 
file ./data/CupAC111S/20131010_30.txt |concentration cu = 30, bca = 70 
[output] 
directory ./output/CupAC111S/20131010_combine 
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BCS binding experiments 
 
[task]  
data = equilibria 
task = fit 
[mechanism] 
cupa + cu <==> cupa.cu : k1 assoc. 
bcs + bcs + cu <==> bcs2.cu : k2 assoc. 
[concentrations] 
cu = 37 
bcs = 200? 
[constants] 
k1 = 1e+7? 
k2 = 6.31e+7 
[responses] 
bcs = 5.7e-5? 
bcs2.cu = 0.0135 
[equilibria] 
variable cupa 
file ./data/CupAM113AM115A/20130415.txt 
[output] 
directory ./output/CupAM113AM115A/20130415 
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Appendix IV XAS study of Cu(I) coordination geometry  
Sample preparation done by Yue Fu. Professor Khadine Higgins performed XAS data 
reduction and analysis for various metallated sCupA and CopAMBD.  Heidi Hu from 
University of Massachusetts, Amherst collected XAS data.  
Methods 
X-ray Absorption Spectroscopy (XAS) sCupA and MBD were concentrated to 2 
mM and 1.2 mM respectively in 25 mM Hepes (pH 7.0) and 200 mM NaCl or NaBr.  0.8 
molar equivalent of CuCl or CuBr was added to both MBD and CupA under anaerobic 
conditions.  30 µL of each sample was syringed into polycarbonate XAS holders that 
were wrapped in kapton tape and frozen in liquid nitrogen.  XAS data were collected at 
beamline 7-3 at the Stanford Synchrotron Radiation Laboratory (SSRL).  Data were 
collected at 10 K using a liquid helium cryostat (Oxford Instruments).  The ring 
conditions were 3GeV and 80-100mA.  Beamline optics consisted of a Si(220) double-
crystal monochromator and two rhodium-coated mirrors. X-ray fluorescence was 
collected using a 30-element Ge detector (Canberra).  Scattering was minimized using 
Soller slits and placing a Z-1 filter between the sample chamber and the detector. 
XANES was collected from ± 200 eV relative to the metal edge.  The X-ray energy for 
the Cu metal Kα-edge was internally calibrated to the first inflection point, 8980.3 eV. 
EXAFS was collected to 15 k above the edge energy (Eo). 
XAS Data Reduction and Analysis The XAS data shown (vide infra) are the average of 
8 scans. XAS data was analyzed using SixPack145.  The SixPack fitting software builds 
on the ifeffit engine146,147. Each data set was background-corrected and normalized.  For 
EXAFS analysis each data set was converted to k-space using the relationship  
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where  is the mass of the electron,  is Plank’s constant divided by 2π, and is the 
threshold energy of the absorption edge.  The threshold energy chosen for copper is 8990 
eV148.  The best fits for the data sets were obtained using a Fourier-transform of the data 
was produced using data over the range k = 2-14 Å-1, where the upper limit was 
determined by the signal:noise ratio. Scattering parameters were generated using FEFF 
8147. The first coordination sphere was determined by setting the number of scattering 
atoms in each shell to integer values and systematically varying the combination of N/O 
and S-donors.  To compare different models of the same data set, ifeffit utilizes three 
goodness of fit parameters: χ2, reduced χ2, and the R-factor. χ2 is given by equation 1, 
where  is the number of independent data points,  is the number of uncertainties 
to minimize,  is the real part of the EXAFS function, and  is the imaginary 
part of the EXAFS fitting function (eq. 1) 
 
 
 
Reduced  where Nvarys is the number of refining parameters and 
represents the degrees of freedom in the fit. Additionally ifeffit calculates the R-factor for 
the fit, which is given by equation 2, and is scaled to the magnitude of the data making it 
proportional to χ2 (eq. 2) 
 
em  oE
idpN 2N
 ifRe  ifIm
 ysind NN var22 /  
(1)
(2)
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In comparing different models, the R-factor and reduced χ2 parameter were used 
to determine which model was the best fit for the data. The R-factor will always generally 
improve with an increasing number of adjustable parameters, while reduced χ2 will go 
through a minimum and then increase, indicating that the model is over fitting the data149. 
Results 
The addition of substoichiometric Cu(I) to sCupA and CopAMBD gives rise to 
Cu(I) near-edge feature in the XANES spectrum whose intensity is consistent with a low-
coordination number complex, either n=2 or n=3 (Fig. 59).  For Cu1 CopAMBD, a best-fit 
of the EXAFS spectrum (as judged by minimizing %R, minimizing reduced χ2, and 
obtaining acceptable σ2 values) is a model corresponding to a digonal bis-thiolato (2S) 
complex in NaBr; in NaCl, a three-coordinate 2S-Cl– fit with a long Cu-Cl– bond (2.42 
Å) is the best fit.  These data and accompanying Cu(I)-S– bond distances (2.18 Å) are 
consistent with Cu(I) binding to the two S1 site thiolate ligands Cys49 and Cys86 (Fig. 
59).  For Cu1 sCupA, the spectra in both NaBr and NaCl are consistent with an n=3 
complex, with a best fit 2S, 1N/O complex, consistent, for example, with recruitment of a 
solvent molecule into the anticipated 2S (Cys74, Cys111) complex (Table 8). As 
expected, XAS analysis of a Cu2 sCupA sample in NaBr gives rise to an average Cu(I) 
coordination environment that is consistent with the crystal structure, including the 
presence of bound Br– anion (Table 9). 
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Figure 59: X-ray absorption near-edge spectra (XANES) of sCupA and CopAMBD. 
XANES of Cu1 CopAMBD (a) and Cu1 sCupA (b) in the presence of 0.2 M NaBr 
(red trace) or 0.2 M NaCl (blue trace).   
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Figure 60: X-ray absorption spectroscopy for Cu0.8 CopAMBD. 
(a), Cu0.8 sCupA (b) and Cu1.8 sCupA (c-d)  in the presence of 0.2 M NaBr or NaCl 
as indicated, to assess the potential influence of a weakly bound anion (Br– or Cl–) 
on the fits.  Both unfiltered k3-weighted EXAFS spectra and Fourier-transformed 
EXAFS data are shown (colored lines) in addition to best fits to each of 
coordination model which results the parameters compiled in Tables 7-9 (black 
lines).  The coordination model with the statistically best-fit of the EXAFS data is 
shown in bold-face in each case.  XANES spectra for the samples shown in panels 
a-b are shown in Fig. 59. Two fits are shown for Cu1.8 sCupA which correspond to 
the statistically best-fit (c) and an alternative fit that includes a Cu-Cu vector at 3.4 
Å (d).  In panel c, the asterisk marks the strong feature associated with Cu-Br– 
coordination bond, while in panel d, the arrow marks the fitted Cu–Cu scattering 
vector (Table 9).  A significant Cu-Cu interaction can not be unequivocally 
extracted from these data, given a comparison of the reduced 2 values for these two 
fits (Table 9).   
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Table 7: EXAFS fits for Cu0.8-CopAMBD.   
Data were fit from k = 2-14 Å-1 and R = 1–2.5 Å.a  
 
N 
 
 
r (Å) 
 
 
σ2 (x10-3 Å2) 
 
ΔEo (eV) 
 
 
% R 
 
 
Reduced 
χ2 
 
 
NaBr 1N/O 2.05(4) 0(3) 8(7) 45.47 25.46 
 2N/O 2.06(1) 0(0.1) 10.37(5) 26.76 15.00 
 3N/O 2.05(2) 2(2) 7(3) 34.79 22.82 
 4N/O 2.04(2) 4(2) 4(3) 49.12 27.50 
 1S 2.18(2) 0.7(8) -2(5) 13.69 7.66 
 2S 2.175(9) 3.9(6) -3(2) 5.68 3.18 
 3S 2.17(2) 7(1) -5(3) 13.31 7.45 
 4S 2.17(2) 9(2) -6(4) 25.67 14.37 
 1S 2.12(2) 1(2)    
 1S 2.22(2) 0.4(2) -4(3) 5.31 3.93 
 2S 2.18(1) 3(1)    
 1N/O 2.2(2) 8(20) -2(7) 2.30 3.25 
 
2S 2.18(1) 3.3(5)    
 2N/O 2.2(1) 20(20) -1(4) 2.21 3.13 
 2S  2.18(2) 5(2)    
 1Br 2.26(4) 11(6) 5(2) 4.54 3.36 
 2S 2.18(1) 3.9(6)    
 1Br 2.62(4) 13(5) -3(2) 4.63 3.43 
 
1N/O 2.01(6) 4(5)    
 1S 2.19(1) 0(1) 1(4) 3.09 4.36 
 2N/O 2.0(1) 20(10)    
 1S 2.18(2) 0(0.9) 1(6) 4.76 6.73 
 3N/O 2.1(2) 30(20)    
 1S 2.18(2) 0(0.8) 0(9) 6.65 9.40 
       
NaCl 1N/O 2.06(5) 0(4) 9(9) 52.38 62.21 
 2N/O 2.08(2) 0(2) 13.75(6) 29.51 35.04 
 3N/O 2.08(1) 0.3(11) 9.75(5) 30.77 36.53 
 4N/O 2.06(2) 2(2) 6(3) 46.66 55.41 
 1S 2.18(2) 0.7(8) -2(5) 13.69 7.66 
 2S 2.177(9) 2.1(5) -3(2) 6.95 8.26 
 3S 2.17(2) 5(1) -4(3) 19.06 22.63 
 4S 2.17(2) 7(2) -6(4) 34.08 40.47 
 1S 2.18(2) 0(0.8)    
 1S 2.3(2) 20(30) 0(9) 8.22 12.91 
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 2S 2.18(1) 2(2)    
 1N/O 2.28(8) 0(4) -3(5) 2.04 6.60 
 2S 2.180(9) 1(1)    
 2N/O 2.21(5) 5(10) 1(4) 2.53 8.19 
 2S  2.193(9) 1.8(5)    
 1Cl 2.42(2) 6(3) 2(2) 3.97 6.23 
 1N/O 2.04(4) 1(7)    
 1S 2.18(2) 0(2) 1(4) 2.85 9.22 
 2N/O 2.04(7) 7(8)    
 1S 2.18(1) 0(2) 1(5) 5.52 17.83 
 3N/O 2.0(1) 10(10)    
 1S 2.18(1) 0(1) 1(7) 9.51 30.72 
aData collected on samples containing 0.2 M NaBr or 0.2 M NaCl as indicated.  The best-
fit is shown in red, bold-face type. 
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Table 8: EXAFS fits for Cu0.8-sCupA.   
Data were fit from k = 2-14 Å-1 and R = 1–2.5 Å.a 
 
N 
 
 
r (Å) 
 
 
σ2 (x10-3 Å2) 
 
ΔEo (eV) 
 
 
% R 
 
 
Reduced 
χ2 
 
 
NaBr 1N/O 2.05(4) 0(3) 7(8) 45.07 36.95 
 2N/O 2.07(1) 0(1) 11.67(5) 20.72 16.99 
 3N/O 2.06(1) 1(1) 7(2) 28.36 23.25 
 4N/O 2.05(2) 3(2) 5(3) 44.67 36.62 
 1S 2.17(1) 0(0.5) -3(3) 6.47 5.30 
 2S 2.170(8) 3.0(4) -5(2) 4.31 3.54 
 3S 2.17(2) 6(1) -6(3) 15.79 12.95 
 4S 2.17(2) 9(2) -7(4) 30.52 25.02 
 1S 2.170(8) 0.5(6) -6(4) 3.20 3.47 
 1S 2.15(7) 9(5)    
 2S 2.18(1) 3(1)    
 1N/O 2.29(3) 0(2) -5(3) 1.90 2.06 
 2S 2.18(1) 2.7(4)    
 2N/O 2.24(9) 16(9) -2(4) 2.50 2.71 
 2S  2.173(9) 2.9(5)    
 1Br 2.52(6) 16(7) -4(2) 4.05 4.39 
 1N/O 2.02(4) 2(3)    
 1S 2.19(1) 0.5(8) 1(3) 2.48 2.69 
 2N/O 2.09(5) 9(8)    
 1S 2.183(8) 0.4(7) 2(4) 4.38 4.75 
 3N/O 2.1(2) 40(30)    
 1S 2.17(2) 0(1) -1(6) 6.35 6.89 
       
NaCl 1N/O 2.05(5) 0(4) 8(9) 49.22 56.70 
 2N/O 2.06(2) 0(1) 7(4) 25.91 29.85 
 3N/O 2.07(1) 0(1) 9.15(5)  27.12 31.24 
 4N/O 2.06(2) 2(2) 5(3) 44.02 50.71 
 1S 2.17(1) 0(1) -2(3) 6.38 7.35 
 2S 2.174(7) 2.4(4) -4(2) 4.70 5.42 
 3S 2.17(2) 5.0(9) -6(3) 17.27 19.90 
 4S 2.17(2) 8(2) -7(4) 32.60 37.55 
 1S 2.18(1) 0(1)    
 1S 2.18(1) 0(1) -2(8) 4.00 6.09 
 2S 2.186(8) 2.4(8)    
 1N/O 2.29(3) 0(2) -4(2) 1.12 1.71 
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aData collected on samples containing 0.2 M NaBr or 0.2 M NaCl as indicated.  The best-
fit is shown in red, bold-face type. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2S 2.184(6) 1.6(7)    
 2N/O 2.21(4) 6(6) 0(3) 1.81 2.76 
 2S  2.185(8) 2.0(4)    
 1Cl 2.41(3) 9(4) -1(2) 3.49 5.32 
 1N/O 2.04(4) 3(4)    
 1S 2.187(8) 0(0.6) 2(3) 1.65 2.52 
 2N/O 2.07(6) 11(8)    
 1S 2.185(8) 0(0.6) 1(2) 3.40 5.18 
 3N/O 2.07(8) 20(10)    
 1S 2.18(1) 0(0.6) 1(5) 6.13 9.34 
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Table 9: EXAFS fits  for Cu1.8-sCupA in 0.2 M NaBr.   
Data were fit from k = 2-14 Å-1 and R = 1–2.5 Å (top) or R = 1–4.0 Å (bottom).a 
 N 
 
 
r (Å) 
 
 
σ2 (x10-3 Å2) 
 
ΔEo (eV) 
 
 
% R 
 
 
Reduced χ2
 
 
1–2.5 Å 1N/O 2.11(4) 0(3) 5(6) 41.89 443.21 
 2N/O 2.11(3) 4(3) 4(3) 31.41 332.35 
 3N/O 2.11(3) 8(4) 3(3) 36.62 387.47 
 4N/O 2.10(5) 12(5) 2(3) 48.38 511.87 
 1S 2.17(1) 2.25(5) 5(3) -6(9) 32.93 
 2S 2.26(3) 10(2) -5(4) 17.30 183.04 
 3S 2.27(3) 14(2) -6(4) 15.47 163.69 
 4S 2.26(3) 17(2) -7(4) 19.32 204.41 
 1S 2.36(2) 1(2) -3(3) 8.00 119.95 
 1S 2.21(2) 1(1)    
 2S 2.30(6) 13(5)    
 1N/O 2.09(6) 4(6) 0(5) 14.35 215.18 
 2S 2.28(5) 11(8)    
 2N/O 2.2(1) 18(76) 0(12) 16.11 241.62 
 2S  2.23(2) 8(1)    
 0.5Br 2.49(2) 5(2) -9(3) 5.84 87.58 
 2S  2.21(2) 9(2)    
 1Br 2.48(3) 9(2) -10(3) 6.51 97.73 
 2S 2.09(5) 9(8)    
 2Br 2.183(8) 0.4(7) -11(4) 7.47 112.07 
 1N/O 2.08(3) 0(2)    
 1S 2.35(3) 6(3) 3(3) 11.12 166.73 
 
 2N/O 2.11(8) 9(8)    
 1S 2.31(6) 10(9) 2(5) 19.22 288.13 
 
1-4.0 Å 2S 2.26(2) 10(2) -6(4) 26.33 114.44 
 3S 2.26(2) 13(2) -6(3) 24.81 120.33 
  
2S 2.21(2) 8(1)    
 1Br 2.48(2) 9(2) -10(3) 16.20 89.20 
  
2S 2.21(2) 8(1)    
 1Br 2.48(3) 9(2)    
 1Cu 3.41(6) 12(6) -10(3) 15.90 101.24 
       
 2S 2.23(2) 8(1)    
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aData collected on samples containing 0.2 M NaBr or 0.2 M NaCl as indicated.  The best-
fit is shown in red, bold-face type (see Fig. AIII.2c for data and fit).  An alternative fit 
with statistics close to the best-fit is highlighted in green, italic type (see Fig. AIII.2d for 
data and fit).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 0.5Br 2.49(2) 4(1) -9(3) 14.81 81.56 
       
 2S 2.23(2) 8(1)    
 0.5Br 2.49(2) 4(1)    
 1Cu 3.41(5) 12(6) -8(3) 14.39 91.63 
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Appendix V. Strain used in the work 
Table 10: Strain table  
 
Strain 
number 
Genotype (description)a Antibiotic 
resistanceb 
K643 D39 ∆cps ∆copA:: Pc-[kanR-rpsL+] (IU1945 transformed 
with ∆copA :: Pc-[kanR-rpsL+] amplicon) 
StrS KanR 
K645 D39 ∆cps ∆cupA:: Pc-[kanR-rpsL+] (IU1945 transformed 
with ∆cupA :: Pc-[kanR-rpsL+] amplicon) 
StrS KanR 
IU1690 D39 (Single colony isolate of serotype 2 strain encapsulated 
D39 NCTC 7466) 
None 
IU1781 D39 rpsL1 (IU1690 transformed with pulA-rpsL1-rpsG-fusA 
amplicon) 
StrR 
IU1945 D39 ∆cps None 
IU3525 D39 rpsL1 ∆copY:: Pc-[kanR-rpsL+] (IU1781 transformed 
with ∆copY :: Pc-[kanR-rpsL+] amplicon) 
StrS KanR 
IU3566 D39 rpsL1 ΔcopY (IU3525 transformed with ΔcopY 
amplicon) 
StrR 
IU5921 D39 rpsL1 ∆cupA:: Pc-[kanR-rpsL+] (IU1781 transformed 
with ∆cupA :: Pc-[kanR-rpsL+] amplicon from K645) 
StrS KanR 
IU5923 D39 rpsL1 ∆copA:: Pc-[kanR-rpsL+] (IU1781 transformed 
with ∆copA :: Pc-[kanR-rpsL+] amplicon from K643) 
StrS KanR 
IU5971 D39 rpsL1 ΔcupA (IU5921 transformed with ΔcupA 
amplicon) 
StrR 
IU5975 D39 rpsL1 ΔcopA (IU5923 transformed with ΔcopA 
amplicon) 
StrR 
IU6015 D39 rpsL1 cupA (C111A; M113A; M115A)  cupA (3A) 
(IU5921 transformed with cupA (3A) amplicon) 
StrR 
IU6017 D39 rpsL1 ΔcupA//∆bgaA'::Pc-kan t1t2-Pfcsk-cupA (IU5971 
transformed with ∆bgaA'::Pc-kan t1t2-Pfcsk-cupA amplicon) 
StrR KanR 
IU6041 D39 rpsL1 cupA-(C)-FLAG (IU5921 transformed with 
cupA-(C)-FLAG amplicon) 
StrR 
IU6044 D39 rpsL1 copA-(C)-FLAG (IU5923 transformed with 
copA-(C)-FLAG amplicon) 
StrR 
IU6050 D39 rpsL1 cupA (C74S) (IU5921 transformed with cupA 
(C74S) amplicon) 
StrR 
IU6052 D39 rpsL1 cupA (C74S; C111A; M113A; M115A))  cupA 
(C74S,3A) (IU5921) transformed with cupA (C74S,3A) 
amplicon) 
StrR 
IU6054 D39 rpsL1 copA (D442A) (IU5923 transformed with copA 
(D442A) amplicon) 
StrR 
IU6084 D39 rpsL1 cupA (∆(2-28)) (IU5921 transformed with cupA 
∆(2-28) amplicon) 
StrR 
IU6086 D39 rpsL1 cupA (∆(2-28)-(C)-FLAG (IU5921 transformed 
with cupA (∆(2-28)-(C)-FLAG amplicon) 
StrR 
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IU6210 D39 rpsL1 cupA (C74S)-(C)-FLAG (IU5921 transformed 
with cupA (C74S)-(C)-FLAG amplicon) 
StrR 
IU6212 D39 rpsL1 cupA (3A)-(C)-FLAG (IU5921 transformed with 
cupA (3A)-(C)-FLAG amplicon) 
StrR 
IU6215 D39 rpsL1 cupA (C74S,3A)-(C)-FLAG (IU5921 
transformed with cupA (C74S,3A)-(C)-FLAG amplicon) 
StrR 
IU6216 D39 rpsL1 ∆cupA-(33-aa remnant)-(C)-FLAG) (IU5921 
transformed with ∆cupA-(C)-FLAGC amplicon) 
StrR 
IU6240 D39 rpsL1 copA (D442A)-(C)-FLAG (IU5923 transformed 
with copA (D442A)-(C)-FLAG amplicon) 
StrR 
IU6245 D39 rpsL1 copA (C49S)-(C)-FLAG (IU5923 transformed 
with copA (D442A)-(C)-FLAG amplicon) 
StrR 
IU6260 D39 rpsL1 ∆copA-(39-aa remnant)-(C)-FLAG (IU5923 
transformed with ∆copA-(C)-FLAG amplicon) 
StrR 
IU6307 D39 rpsL1 cupA (C74S) copA-(C)-FLAG (IU5923 
transformed with cupA (C74S) copA-(C)- FLAG amplicon) 
StrR 
IU6308 D39 rpsL1 ∆cupA copA-(C)-FLAG (IU 5923 transformed 
with fusion ∆cupA copA-(C)-FLAG amplicon) 
StrR 
IU6585 D39 rpsL1 cupA (M113A; M115A)  cupA (2A) (IU5921 
transformed with cupA (2A) amplicon) 
StrR 
All FLAG-tagged fusions ((C)-FLAG) were made to the carboxyl end (C) of reading 
frames. The amino acid sequence for the FLAG epitope is DYKDDDDK14,150. aa = 
amino acids.  bAntibiotic resistance markers: KanR, kanamycin; StrR, streptomycin, 
Concentrations of antibiotics used for S. pneumoniae strains: 250 µg Str per mL (Sigma 
S6501) and 250 µg Kan per mL (Sigma K0254).  
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